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1.1 INTRODUCTION 
Malignant lymphoma is the collective name for primary 
malignant tumors of lymphoid tissue. Two main categories 
are distinguished: Hodgkin disease (HD) and the non-
Hodgkin lymphoma's (NHL). 
HD and NHL not only differ in histopathologic structure, 
but also in the way of clinical presentation, course of 
disease, responsiveness to therapy and overall survival. 
The malignant lymphomas were responsible for 3% of first 
hospital admissions due to malignant neoplasms in the 
Netherlands in 1983. NHL constituted the largest group 
with 2% (7 cases per 100.000 inhabitants) and HD was 
diagnosed in 1% (3.2 cases per 100.000 inhabitants). 
Registrated mortality due to NHL was 726 cases in 1983, or 
2.3% of all cancer deaths. Mortality due to HD was 137 
cases, or 0.4% of all cancer deaths (1). 
In view of the differences between HD and NHL, a separate 
discussion of the radiologic tribute to the staging and 
management of these diseases is desirable and justified. 
Earlier radiologic literature - especially on computed 
tomography - frequently presents combined findings in HD 
and NHL. In the present study, however, the distinction 
between the two diseases is maintained whenever 
appropriate. 
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1.2 GENERAL INFORMATION 
1.2.1 Hodgkin disease (HD). 
HD was first described in 1832 by Thomas Hodgkin, whose 
name was actually linked to the disease by Sir Samuel Wilks 
in 1865 (2). One hundred years later Lukes et al. developed 
a pathologic classification, which was accepted in its 
final form as the standard histopathologic classification 
at the Rye conference ( 3,4). The diagnostic cell-component 
is the Reed-Sternberg cell, which is a large, binucleated 
cell. In association with similar mononuclear cells, this 
cell is assumed to represent the neoplastic cell component 
of the disease. 
The Rye classification distinguishes the following types of 
HD: 
1. Lymphocytic £redominance (LP_)_: 10 to 15% of adult HD-
cases. This type typically manifests itself with an 
early stage in young, asymptomatic males, and has the 
most favourable prognosis. Histologically, abundant 
small lymphocytes and/or histiocytes dominate the 
picture, and Reed-Sternberg cells may be scarce. 
2. Nodular^  scleroses iNS)^. 20 to 50% of adult HD-cases. 
This type has a female predominance, with a peak 
incidence in adolescence and early adulthood. The 
prognosis is very good when diagnosed at an early stage. 
Histologically, nodules of lymphoid tissue, encircled by 
bands of collagen tissue are to be seen. Both the degree 
of sclerosis and the cellular composition including the 
Reed-Sternberg cell show numerous variations in 
manifestation. 
3. Mixed cellularit^ lMC)j_ 20 to 40% of adult HD-cases. 
These patients often show systemic symptoms. Prognosis 
is less favourable than for the above-mentioned forms. 
Histologically, a highly cellular, pleomorphic stroma 
is to be seen, with numerous Reed-Sternberg cells, 
mononuclear Hodgkin cells, eosinophils, plasmacells and 
fibroblasts. 
4. Lymphocyte_depletion_(LDJ^ 5 to 15% of adult HD-cases. 
This generally occurs in older, symptomatic patients 
with stage III or IV at initial diagnosis, and has an 
unfavourable prognosis. 
Histologically, a diffuse or reticular fibrotic stroma 
is to be seen, with few lymphocytes, and usually 
abundant Reed-Sternberg cells. 
With modern radiotherapy and chemotherapy, the present 5-
year and 10-year survival rates for patients with HD have 
improved. They now range from 90% and 79% respectively for 
stage I disease, to 57% and 40% respectively for stage IV 
disease (5). 
1.2.2 Non-Hodgkin lymphoma (NHL). 
Non-Hodgkin lymphoma is a heterogeneous group of neoplasms 
that vary in clinical presentation, course, prognosis and 
radiological manifestations. In earlier nomenclature, the 
terms lymphosarcoma, reticulum-cell sarcoma, and giant 
follicular lymphoma (Brill-Symmers disease) were used up 
to the sixties. Since then, various histopathologic 
classifications were developed of which the Rappaport, 
Lukes & Collins and the Kiel/Lennert classifications are 
the most familiar. 
None of these classifications was definitely superior, and 
after an extensive assessment of histologic material by 
experienced pathologists and comparison of the results the 
so-called "Working Formulation of non-Hodgkin lymphoma for 
clinical usage" was developed (6). By using this formula, 
it became possible to "translate" one system into an 
other, making it possible to compare data from different 
centers. The "Working Formulation" distinguishes the 
malignant lymphomas into categories of low, intermediate 
and high grades of malignancy, relating to the clinical 
Table I 
CLASSIFICATIONS of NON-HODGKIN's LYMPHOMAS 
A Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage 
(equivalent or related terms in the Kiel classification are shown) 
Working Formulation Kiel equivalent or related terms 
grade 
A. Malignant lymphoma 
Small lymphocytic 
consistent with CLL 
plasmacytoid 
B. Malignant lymphoma, follicular 
Predominantly small cleaved cell 
diffuse areas 
sclerosis 
C. Malignant lymphoma, follicular 
Mixed, small cleaved and large cell 
diffuse areas 
sclerosis 
ML lymphocytic, CLL 
ML lymphoplasmacytic/lymphoplasmacytoid 
ML centroblastic-centrocytic (small), 
follicular ± diffuse 
E. 
Intermediate grade 
D. Malignant lymphoma, follicular 
Predominantly large cell 
diffuse areas 
sclerosis 
Malignant lymphoma, diffuse 
Small cleaved cell 
sclerosis 
Malignant lymphoma, diffuse 
Mixed, small and large cell 
sclerosis 
epithelioid cell component 
Malignant lymphoma, diffuse 
Large cell 
cleaved cell 
noncleaved cell 
sclerosis 
ML centroblastic-centrocytic (large), 
follicular ± diffuse 
ML centrocytic (small) 
ML centroblastic-centrocytic (small), diffuse 
ML lymphoplasmacytic/-cytoid, polymorphic 
ML centroblastic-centrocytic (large), diffuse 
ML centrocytic (large) 
ML centroblastic 
High grade 
H. Malignant lymphoma 
Large cell, immunoblastic 
plasmacytoid 
clear cell 
polymorphous 
epithelioid cell component 
I. Malignant lymphoma 
Lymphoblastic 
convoluted cell 
nonconvoluted cell 
J. Malignant lymphoma 
Small noncleaved cell 
Burkitt's 
follicular areas 
Miscellaneous 
Composite 
Mycosis fungoides 
Histiocytic 
Extramedullary plasmacytoma 
Unclassiflable 
Other 
ML immunoblastic 
T-zone lymphoma 
Lymphoepithelioid cell lymphoma 
ML lymphoblastic, convoluted cell type 
ML lymphoblastic, unclassified 
ML lymphoblastic, Burkitt type and other 
B-lymphoblastic 
Mycosis fungoides 
ML plasmacytic 
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behaviour (table I). In the Netherlands, the Kiel/Lennert 
classification is usually preferred. 
According to data from the National Cancer Institute (7), 
the overall 5-year survival in 1984 for NHL was 48%.This 
figure varies from 85-100% in favourable histologies in 
stages I and II, to 25-50% for unfavourable histologies in 
stages III and IV (8). 
1.3 STAGING 
Once the histopathological diagnosis of HD or NHL is made 
-usually by a biopsy from a peripheral lymph-node region-
the patient must undergo a series of staging examinations 
to determine the spread of disease through the body. 
HD and NHL differ in the manner and extent of disease, 
diagnosed at initial examination. 
Whereas HD apparently shows an orderly spread of disease 
by contiguity and in a relatively predictable manner (9), 
NHL usually is more disseminated at the time of initial 
diagnosis, and more frequently shows organ involvement 
(table II; ref. 10). 
Table II: Anatomic sites involved at presentation (%). 
HD NHL 
thoracic nodes 
lung parenchyma 
pleural effusion 
para-aortic nodes 
mesenteric nodes 
spleen 
liver 
G-I tract 
urinary tract 
The description of disease extent in HD occurs according 
to the Ann Arbor classification (11; table III). This 
system is also applicable to NHL. 
65 
10 
10 
34 
<5 
34 
6 
0 
0 
25 
4 
7 
55 
51 
33 
14 
8 
3 
- 7 -
Table I I I : Ann Arbor Staging classification 
Stage I : Involvement of a single lymph-node 
region (I) or of a single extra-
lymphatic organ or s i te (Iß). 
Steige II : Involvanent of two or more lymph-node 
regions on the sane side of the dia-
phragm (II) or localized involvement of 
an extralymphatic organ or s i te and of 
one or more lymph-node regions on the 
same side of the diaphragm (IIg). 
Stage I I I : Involvement of lymph-node regions on 
both sides of the diaphragm ( I I I ) , 
viiich may also be accompanied by 
involvement of the spleen (Il ls) or 
by localized involvanent of an extra-
lymphatic organ or s i te ( I I I E ) or 
both ( I I I S E ) . 
Steige IV : Diffuse or disseminated involvanent of 
one or more extralymphatic organs or 
t issues, with or without associated 
lymph node involvanent. 
The absence or presence of fever (>38*), night 
sweats, and/or unexplained loss of 10% or more of 
body weight in the 6 months preceding admission 
are to be denoted in a l l cases by the suffix 
le t ters A or В respectively. 
A d i s t i n c t i o n i s made between the c l i n i c a l s t a g e (CS) and 
the p a t h o l o g i c a l s t a g e (PS). 
The former i s based on data from the i n i t i a l biopsy s i t e , 
p a t i e n t h i s t o r y , p h y s i c a l examinat ion, l a b o r a t o r y t e s t s , 
r a d i o l o g i c and r a d i o i s o t o p e s t u d i e s , and bone marrow 
examinat ion. A l i v e r biopsy i s performed when the p a t i e n t 
a t t h i s time has not yet proven g e n e r a l i z e d d i s e a s e or 
B-symptoms. 
The definition of PS is based on evidence from staging 
laparotomy, which includes splenectomy, and multiple 
biopsies of lymph nodes, liver and bone marrow. 
Staging laparotomy was introduced in the late sixties at 
Stanford Medical School for patients with HD and NHL. It 
soon became obvious that the clinically determined stage 
of disease underestimated the actual extent of disease in 
30-40% of patients (5). The method was widely accepted 
and applied, but in later years, due to more modern views 
on classification and treatment, the indications for 
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laparotomy became more specific. 
Nowadays, indications for staging laparotomy are only 
given in selected patients, and - especially in NHL -, are 
only rarely present. 
1.4 IMAGING PROCEDURES 
1.4.1 Radiologic procedures 
Chest radiography and tomography, computed tomography (CT) 
of the chest and abdomen, and lymphography of the 
infradiaphragmatic nodes are the subjects of discussion in 
the following chapters. The reader is referred to the 
specific chapters. 
Before the advent of CT, intravenous urography (IVU) was 
used to gain an impression of the retroperitoneal lymph 
nodes by visualizing the course of the ureters. At the 
same time, the renal parenchyma could be evaluated, which 
is rarely involved with NHL. Also, inferior vena 
cavography was performed at times to evaluate potential 
enlargement of retroperitoneal lymph nodes which escaped 
visualization with lymphography. Nowadays these techniques 
are not used anymore for routine staging. 
1.4.2 Radionuclide studies 
Gallium 67 citrate or Technetium 99 microcolloid studies 
are used in certain institutions for detection of lymphoma 
sites in the body. In general, these examinations will not 
obviate the need for other radiologic imaging techniques 
and it is therefore not performed routinely in the St. 
Radboud Hospital. 
Isotope scanning can be of use for determination of size 
of liver and spleen, and for the possible presence of 
large lesions. Since the introduction of CT, the 
examinations have only been rarely done. 
Bone scanning can give indications of the presence of 
osseous lesions, but since the technique has a relatively 
low specificity it is not routinely used during initial 
staging. 
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1.4.3 Ultrasonography 
Modern real-time ultrasound techniques have the potential 
to visualize enlarged lymph nodes, and lymphomatous 
deposits in liver and spleen. Ultrasound imaging is most 
successful in the upper abdomen. The caudally situated 
para-aortic and parailiac nodes, and the mesenteric nodes 
are more difficult to visualize, unless they are markedly 
enlarged. Generally, ultrasonography does not obviate the 
need for an abdominal CT scan or lymphogram. Ultra-
sonography can be of value in the case of equivocal CT 
findings in the upper abdomen especially in slender adults 
and children. It can also be of use in the follow-up of 
large abdominal masses to monitor the effects of therapy. 
In the St. Radboud Hospital ultrasonography is at present 
used for staging children with malignant lymphoma, and not 
for adult patients. The technique was only sporadically 
applied in the patient groups that were the subjects of 
the present studies. 
1.4.4 Magnetic Resonance Imaging (MRI) 
This newly applied technique is based on the use of 
magnetic fields and radiofrequency signals in imaging 
certain atoms (usually protons), without the use of 
ionizing radiation. With MRI, it is possible to visualize 
body regions in freely chosen planes, which occasionally 
facilitates localization of disease. The diagnostic 
performance is at the moment inferior to CT, but 
techniques are rapidly improving. Series comparing CT and 
MRI findings, or MRI and histologic findings in lymphoma 
patients are not yet available in medical literature. MRI 
may contribute to the development of tissue 
characterization in vivo, but data have still to be 
generated. 
1.5 THE PRESENT STUDY 
The choice of optimal therapy for patients with malignant 
lymphoma calls for an accurate determination of disease 
- 10 -
extent to avoid over- or undertreatraent. 
Radiologic examinations are non-invasive methods which can 
show a multitude of potential sites of involvement. The 
various techniques applied determine to a large extent the 
so called "clinical stage" which serves as a reliable 
alternative for the "pathological stage" with many 
patients. While in some respects the techniques are 
competitive by producing similar information, they can be 
complementary in other respects by producing unique 
information. Furthermore, it is not always necessary to 
produce the highest degree of accuracy attainable in 
clinical staging, as other factors -e.g. the histologic 
type of disease- influence the choice of therapy as well. 
From a radiologic point of view the chest and abdomen are 
the main regions of interest in staging patients with 
malignant lymphoma. The soft tissues and skeletal parts of 
the extremities, the head and neck region, and the central 
nervous system are not routinely screened radiologically 
in asymptomatic subjects, because of the very low yield. 
Although the same radiologic techniques are equally 
important in the follow-up of patients during and after 
treatment, this aspect is not part of the present study. 
The main subject is the evaluation of radiologic 
techniques in staging patients with newly diagnosed and 
untreated malignant lymphoma, or restaging patients with 
recurrent disease after a period of complete remission. 
1.5.1 The abdomen 
1.5.1.1 The lymph nodes 
Lymphography and -more recently- CT are available to 
examine the infradiaphragmatic nodes. CT also offers the 
possibility to examine other organ systems in the abdomen, 
and to visualize more lymph-node regions than 
lymphog raphy. 
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In chapter 2 and 4 the diagnostic performance of CT and 
lymphography in HD and NHL respectively are discussed. 
Literature data are summarized, and own results are given. 
The main goal is to determine whether the two methods are 
overlapping, competitive or complementary, and to answer 
the question what would be required for optimal staging. 
1.5.1.2 The spleen 
Staging laparotomy showed the unreliability of non-
invasive examination methods for determining the presence 
or absence of lymphoma in the spleen. 
In chapter 3 and 5 the results of CT-based estimations of 
size of the spleen in relation to its histologic state, in 
patients with HD and NHL respectively are presented. 
The critical comments by radiodiagnostic experts from 
Stanford Medical School following chapter 3 show that our 
concepts of splenic index calculation remain subject of 
discussion. 
1.5.2 The chest 
The chest can be examined for lymphoma by conventional 
radiography, conventional tomography or computed 
tomography (CT). These 3 techniques are increasingly 
accurate in the same order, but also more costly, and 
cumbersome to the patient. 
In chapter 6 the literature is reviewed, and the results 
with our patients are presented. The diagnostic 
performance of each examination is evaluated, and the 
results are analysed to define the most desirable approach 
in the examination of the chest for staging purposes. 
1.5.3 Uncommon manifestations 
In chapter 7 the uncommon radiologic observation of 
calcification in lymph nodes, afflicted with HD and NHL is 
described. The literature is reviewed, and the clinical 
significance is indicated. 
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ABSTRACT 
Lymphography and abdominal CT were performed in 78 
patients staged for Hodgkin disease. In 82% of all 
patients, both examinations agreed on the presence or 
absence of lymph-node involvement. In the group of 39 
patients undergoing lymphography prior to CT, the 
agreement was 90%. In the group of 39 patients with 
lymphography following CT, the agreement was 74%. In 50% 
of the patients with discrepant findings, lymphography 
revealed abnormal nodes compared with CT. Lymphography was 
abnormal in 26% of patients with a normal CT scan for the 
first examination, and in 9% of patients with a normal CT 
scan for the second examination. 
It is concluded that lymphography is more reliable than CT 
with regard to the examination of the infradiaphragmatic 
lymph nodes. 
CT performed after a normal or an abnormal lymphogram adds 
little additional information. 
When CT is preferred as the initial examination in staging 
Hodgkin disease, lymphography only adds significant 
information when the CT scan is normal or equivocal. 
INTRODUCTION 
The development of effective treatment regimens in Hodgkin 
disease (HD) was partly based on the application of 
careful staging procedures to create patient groups with 
comparable states of disease. As final procedure, staging 
laparotomy with histologic examination of multiple tissue 
samples allowed a reliable determination of the so-called 
"pathological stage". As a result of this the diagnostic 
value of various non-invasive examination methods could 
not only be tested critically, but diagnostic criteria 
could also be formulated and adapted after comparison with 
histologic data. 
In this way, lymphography has evolved into one of the most 
important radiologic staging examinations in HD, and this 
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is illustrated by numerous publications. Within a few 
years after its clinical application, Computed Tomography 
(CT) also managed to secure a place of its own in the 
staging process, although large series were not provided 
as liberally as with lymphography. Various authors have 
analysed the comparative value of CT and lymphography in 
staging HD, coming to different conclusions. Castellino et 
al. (1) conclude in a series of 107 patients that 
lymphography has a small but real advantage over CT. 
Crowther (2) draws the opposite conclusion in a series of 
105 patients. 
In the present report, the radiologic examination of 
abdominal lymph nodes by CT and lymphography in 78 
patients with HD is analysed, with particular reference to 
the causes of discrepant and contradictory findings. 
MATERIAL AND METHODS 
During the years 1978 to 1985 lymphography and abdominal 
CT were performed in 78 patients with HD. Sixty-two 
patients had newly diagnosed, previously untreated 
disease, and 16 patients were staged for recurrent 
disease. The most common histologic subtype was nodular 
sclerosis (46), followed by mixed cellularity (14), 
lymphocyte predominance (10) and lymphocyte depletion (4). 
Four cases were unclassified. 
Fifty-three patients were male, with an age range of 11 
to 72 years (mean age 33 yrs.). The age of the 25 female 
patients ranged from 14 to 68 years (mean age 36 yrs.). 
Bipedal lymphography was performed using standard 
techniques, with a total dose of 10 to 12 ml Lipiodol 
Ultrafluid in adult patients. 
CT of the body was performed in 44 patients on an OHIO 
Nuclear 50 FS Delta Scanner with a scanning time of 18 
seconds and a section thickness of 13.5 mm. Contiguous 
scanning of the whole abdomen was performed with the scans 
of the upper abdomen in suspended expiration. Twenty-nine 
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patients were examined on a Siemens Somatom DR 3 with a 
scanning time of 5 seconds and a section thickness of 8 mm 
at 16 mm intervals. Five patients were referred with a CT 
scan made elsewere. Intravenous contrast material was not 
administered routinely. Generally speaking lymph nodes 
larger than 1.5 cm were called pathologic, whereas nodes 
up to 1 cm were regarded to be normal. Nodes with an 
intermediate size were regarded as suspect or equivocal. 
For lymph nodes containing contrast medium after 
lymphography, limits were slightly higher, but not well 
defined. 
The order in which CT and lymphography were carried out 
was determined rather arbitrarily, mainly depending on 
scheduling facilities. 
The original interpretations of the lymphograms and the CT 
scans were maintained. In general, the report of the first 
examination was available to the radiologist performing 
the second examination. Although CT has the potential to 
visualize more lymph-node regions than lymphography, the 
overall conclusions of both examinations with regard to 
the lymph-node status (positive, negative, equivocal) were 
compared. Revision was only undertaken for better 
definition of the sites of lymph node involvement, and of 
the areas and causes of discrepancy. 
Laparotomy with splenectomy was performed in 30 patients 
(1 patient with recurrent disease). Of the 16 patients 
with recurrent disease, 12 had previous laparotomy with 
splenectomy. In general, indications for staging 
laparotomy were clinical stages IIA or IIIA, that might 
be considered candidate for (loco)regional radiotherapy 
only, or patients with primary infradiaphragmatic disease 
presentation. In 3 patients removal of an enlarged spleen 
prior to the start of therapy was the main indication. 
Evaluation of computed tomographic findings of the spleen 
has been the subject of a previous study (3), and will not 
be dealt with separately here. 
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RESULTS 
The comparat i ve r e s u l t s of CT and lymphography a r e 
summarized i n t a b l e s I a - c . Both i n t h e whole group and i n 
t h e two subgroups , 50% of t h e d i s c r e p a n t f i n d i n g s 
c o n s i s t e d of a combinat ion of a normal CT s c a n and an 
abnormal lymphogram, 7 p a t i e n t s i n a l l . In a l l t h e s e 
p a t i e n t s t h e lymphogram was p o s i t i v e due t o s t r u c t u r a l 
changes i n nodes of normal s i z e . Of t h e s e 7 p a t i e n t s , 5 
have been i n c l u d e d i n t h e group w i t h CT c a r r i e d out b e f o r e 
lymphography ( f i g s . 1 - 2 ) . 
Table I a-c; Comparison of СГ and lymphography report in 
78 pat ients. 
Table I a; Overall resu l ts . Concordance 64/78 = 82%. 
CT 
lympho­
graphy 
-
+ 
± 
total 
_ 
32 
7 
2 
41 
+ 
3 
32 
35 
± 
1 
1 
2 
total 
36 
40 
2 
78 
Table I b; Conparison of CT and lymphography in 39 
patients with lymphography performed before СГ. 
Concordance 3 5 / 3 9 = 90%. 
CT 
lympho­
graphy 
_ 
+ 
± 
_ 
19 
2 
1 
+ 
1 
16 
± 
total 
20 
18 
1 
t o t a l 22 17 39 
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Table I с; Comparison of CT and lymphography in 39 
patients with CT performed before 
lymphography. Concordance "^/yj = 74%. 
CT 
lympho­
graphy 
-
+ 
± 
total 
-
13 
5 
1 
19 
+ 
2 
16 
18 
± 
1 
1 
2 
total 
16 
22 
1 
39 
Three patients showed the combination of a normal 
lymphogram and an abnormal CT scan: 1 patient with 
recurrent disease showed enlarged retrocrural nodes only, 
with normal retroperitoneal findings on CT and 
lymphography. One patient was thought to have enlarged 
iliac nodes with CT, but subsequent lymphography revealed 
no abnormalities. The third patient was presumed to have 
enlarged retropancreatic and retrocrural nodes, and normal 
lower retroperitoneal findings on CT and lymphography. 
Laparotomy in this patient revealed an involved spleen and 
involved celiac nodes only. The 4 remaining discrepancies 
were equally distributed over the other possible 
combinations, and in each case one of the examinations was 
reported as equivocal. 
After comparing and weighing the CT and lymphography 
reports, the final (radiological) staging data showed that 
34 patients were negative, 42 patients were positive, and 
2 patients were equivocal with regard to the 
infradiaphragmatic lymph-node status. 
Fourty-four patients were examined on the (slower) 2nd 
generation scanner, and discrepant findings in comparison 
with lymphography were recorded in 4 (= 9%). Thirthy-four 
patients were examined with the (faster) 3rd generation 
scanner, and discrepant findings were recorded in 10 cases 
(= 29%). 
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Fig. 1: Male patient of 32 years with 
HD, nodular sclerosing type. 
Normal-sized nodes on CT (la). 
Lymphography reveals minimally 
enlarged nodes with diffuse, 
foamy appearance, suggestive 
of HD (lb). 
a = aorta ν = v. cava inferior 
Fig. 2: Male patient of 64 years with HD, nodular sclerosing type. 
CT shows normal-sized retroperitoneal nodes (2a). 
Subsequent lymphography also reveals irregular structure 
filling defects, suggestive of HD (2b). 
and 
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Laparotomy was performed in 30 p a t i e n t s . With 3 p a t i e n t s 
o n l y s p l e n e c t o m y was p lanned, and abdominal nodes were not 
b i o p s i e d . With 2 p a t i e n t s , t h e r a d i o l o g i c a l l y s u s p e c t 
nodes were not removed. Th i s l e a v e s 25 p a t i e n t s for 
r a d i o l o g i c - h i s t o l o g i c c o r r e l a t i o n of lymph nodes ( t a b l e 
I I . ) 
Table I I ; Comparison of radiologic and h is to log ic findings in 25 
patients undergoing laparotomy with lymjh-node s a m p l i n g . 
accuracy sens i t i v i ty s p e c i f i c i t y 
lymphography 23/25 (92%) 7/9 (78%) 16/16 (100%) 
(contrast f i l l e d nodes) 
lymphography 21/25 (84%) 7/11 (64%) 14/14 (100%) 
( a l l lymph nodes) 
CT (a l l lymph nodes) 20/25 (80%) 7/11 (64%) 13/14 (93%) 
СГ + lymphography 22/25 (88%) 9/12 (75%) 13/13 (100%) 
Accuracy = Sim of correctly posit ive and negative d iagnoses in 
the group. 
Sens i t iv i ty = Correct diagnosis in patients having the d i s e a s e . 
Speci f ic i ty = Correct diagnosis in patients not having the d i s e a s e . 
The d i a g n o s t i c a c c u r a c y of lymphography i n comparison w i t h 
h i s t o l o g y of t h e v i s u a l i z e d lymph nodes amounted t o 92%, 
w i t h a s e n s i t i v i t y of 78% and a s p e c i f i c i t y of 100%. In 2 
p a t i e n t s , a f f e c t e d nodes were found i n t h e upper para­
a o r t i c ( c e l i a c ) r e g i o n o n l y , o u t s i d e t h e s c o p e of t h e 
lymphogram. If t h e lymphogram was regarded t o r e p r e s e n t 
a l l abdominal lymph-node r e g i o n s , t h e d i a g n o s t i c accuracy 
would drop t o 84% and t h e s e n s i t i v i t y t o 64%. The 
s p e c i f i c i t y remains 100%, however. 
The d i a g n o s t i c a c c u r a c y of CT - p o t e n t i a l l y v i s u a l i z i n g a l l 
abdominal lymph-node r e g i o n s - amounted t o 80% w i t h a 
s e n s i t i v i t y of 64% and a s p e c i f i c i t y of 93%. 
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Retroerural lymph iiodes^ : 
The CT scans of 76 patients were inspected for the 
presence of enlarged retrocrural lymph nodes (i.e. nodes 
larger than 6 mm (4)). Out of the 40 patients with 
pathologic abdominal nodes on CT or lymphography, 7 also 
revealed enlarged retrocrural nodes (18%). Only 1 patient 
showed enlarged retrocrural nodes in the absence of other 
abdominal lymph-node involvement. Six out of the total of 
8 patients having retrocrural lymph-node enlargement also 
had enlarged mediastinal or hilar nodes on the chest 
X-ray, and in the remaining 2 patients findings in the 
chest were normal. 
DISCUSSION 
Hodgkin disease has to a large extent become a curable 
disease. Even advanced stages of primary or recurrent 
disease can nowadays be treated effectively. 
On the other hand, there is a tendency to minimize 
treatment in the less advanced stages to avoid early and 
late side effects of chemotherapy and/or radiotherapy, 
such as pulmonary and cardiac damage, hypothyroidism, 
infertility, bone-marrow depression, and the development 
of secondary malignancies such as leukemia or non-Hodgkin 
lymphoma (5). Accurate staging is mandatory to tailor 
treatment to the stage, and to prevent over- or 
undertreatment. 
Lymphography has become a major method for imaging the 
retroperitoneal lymph nodes. Numerous publications have 
appeared correlating radiologic and histologic findings 
(6-24; fig. 3). The total number of patients represented 
in figure 3 is 1903. Many series illustrate that an 
overall diagnostic accuracy of 90% or higher is 
obtainable. The mean accuracy rate is 87%. The associated 
sensitivity varies between 55% and 100%, with a mean value 
of 81%. The specificity varies between 72 and 100%, with a 
mean value of 89%. 
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Comparable data on CT and histology of lymph nodes in HD 
are not as widely available. 
Fig. 4 is a compilation of literature data presenting 
histologically controlled CT-studies in patients with HD. 
Series presenting mixed data on HD and NHL are not 
incorporated. From institutions publishing regularly, only 
the most recent data available from medical literature are 
included (1,2,6,8,25-28). The total number of patients 
represented in figure 4 is 441. The series of Castellino 
et al. (1) and Crowther (2) contain more than 100 patients 
each, the series of Clouse et al. (6) contains 54 
patients, and the remaining series all consist of less 
than 40 patients. The relative scarcity of abdominal CT-
evaluations is in contrast with the abundance of 
publications on lymphography in HD, but this is probably 
due to the fact that staging laparotomy is nowadays 
applied far less than before. The diagnostic accuracy of 
CT varies between 66% and 95%, with a mean value of 83%. 
The sensitivity in detecting lymph-node involvement varies 
from 26% to 100% (mean value 62%), and the specificity 
from 86% to 100% (mean value 92%). 
These literature data indicate that the difference in 
diagnostic accuracy between CT and lymphography is due to 
the lower sensitivity of CT in detecting lymph-node 
involvement, or -in other words- CT leads to more false-
negative diagnoses. 
This general conclusion supports the conclusion of 
Castellino et al. (1). These authors established an 
overall accuracy for lymphography of 95%, and for CT of 
87%. The figures for sensitivity were 85% and 65% 
respectively, and for specificity 98% and 92% 
respectively. Crowther (2) however, found a slightly 
greater sensitivity of CT in comparison with lymphography, 
even in the lymph-node areas covered by lymphography. 
According to the literature data, the combined use of CT 
and lymphography in the same patients leads to discrepant 
findings in 4% to 33% of cases. (9,16,27-32). These 
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discrepancies consist mainly of normal CT-findings in 
combination with an abnormal lymphogram, and this is also 
illustrated by our personal series. 
The overall discrepancy rate between CT and lymphography 
in our series of 78 patients was 18% (14 patients). When 
CT was the first examination performed, the discordance 
was greater than when lymphography was carried out first 
(26% and 10% respectively). This difference is probably 
due to the fact that in our clinical setting the diagnosis 
of the first examination is generally known to the 
radiologist performing the second examination. For the 
purpose of this study, we maintained the original reports, 
without retrospective modification. Apparently it happens 
that the primary lymphographic diagnosis is adopted when 
interpreting the subsequent CT scan, and only 2 false-
negative CT scans occurred in this group (one case with 
histologic proof). The group of 39 patients undergoing CT 
prior to lymphography included the remaining 5 "false-
negative" CT scans (one with histologic proof). There were 
also 2 equivocal CT-diagnoses in this group that were 
subsequently modified into normal and pathologic findings 
respectively by lymphography (one case with histologic 
proof). The fact that "false-negative" CT scans were 
surprisingly more frequent with the faster scanner, cannot 
be explained adequately. It seemed that an "equivocal" 
diagnosis was avoided in exchange for a "negative" 
diagnosis, in the knowledge that a lymphography would be 
carried out. It is suggested by our data, that the 
CT-diagnosis is more reliable when the examination is 
performed following lymphography, and its interpretation 
is known. This suggestion is corroborated by our study of 
patients with NHL undergoing both procedures. Comparable 
results were obtained with those patients (33). 
A fair comparison of the diagnostic value of CT and 
lymphography can therefore only be made when the CT is 
performed first, and when the examinations are interpreted 
prospectively and independently. 
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Castellino et al. (1 ) conclude that in their hands 
lymphography has a real diagnostic advantage over CT in 
evaluating the retroperitoneal lymph nodes in 7 % of 
cases. Although our number of patients is considerably 
smaller especially when laparotomy is concerned, the 
comparison of CT and lymphography results in the total 
group of 78 patients makes clear that lymphography 
overruled the CT diagnosis in 9 patients (* 12%), whereas 
CT added information on the lymph-node status in only 1 
patient (= 1%). 
The answer to the question whether either one or both 
examinations should be performed in order to obtain the 
most accurate clinical staging data is determined by the 
influence these data will have on the final treatment 
strategy. Therefore a uniformly valuable answer can not be 
given. The following considerations may help in answering 
this question. A CT scan showing abdominal lymph-node 
enlargement generally does not have to be followed by a 
lymphogram, because false-positive CT-findings are 
uncommon. A normal abdominal CT scan excludes bulky 
disease in the lymph nodes, but minor abnormalities can 
still be found by lymphography in 10 to 20% of cases. When 
this uncertainty does not change treatment strategy, 
lymphography can be omitted. 
Performing lymphography only, without subsequent CT 
scanning does not decrease the reliability of nonainvasive 
staging, because CT only rarely adds significant 
information on the lymph nodes. Although it is known that 
staging laparatomy can detect unexpected abdominal lymph 
node involvement after a normal lymphogram, these findings 
could only occasionally have been detected by CT. 
The diagnostic errors in our series of 25 patients 
undergoing staging laparotomy with appropriate lymph-node 
sampling occurred in the upper abdominal lymph nodes in 3 
of 4 cases. One patient showed a small focus of HD in a 8 
mm large node, containing contrast medium after 
lymphography. This focus was clearly too small to be 
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visualized with CT or lymphography, even in retrospect. 
One patient showed involvement of a normal-sized spleen, 
splenic hilar, peripancreatic and celiac nodes. These 
nodes were situated outside the scope of the lymphogram, 
but on reviewing the CT scan, some of these nodes could be 
located (fig . 5 ). 
Fig. 5: Female patient of 34 years with HD, mixed cellular type. CT 
scan originally misinterpreted as showing no abnormalities. Staging 
laparotomy revealed an involved spleen and enlarged retropancreatic 
nodes, which were radiologically visible in retrospect (arrows) . 
In the third patient, CT was misinterpreted as showing 
enlarged retropancreatic and retrocrural nodes. Staging 
laparotomy revealed an involved normal-sized spleen and 
celiac nodes only. 
In a fourth patient, staging laparotomy with histologic 
examination confirmed the negative CT and lymphography 
reports. However, a clinically suspect, superficial left 
inguinal lymph node was removed, and this node proved to 
be affected by HD. In retrospect, the node could be 
located, but definitive signs of malignancy could not be 
established radiologically. Finally, one patient was 
proven to have an involved spleen only after staging 
laparotomy, with negative findings at lymphography and CT 
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of lymph nodes being confirmed. 
When CT and lymphography produce discrepant results in 
staging, the interpretation of the latter is generally 
preferred because lymph-node structure of apparently 
involved nodes usually presents characteristic images and 
therefore more specific information than assessment of 
size alone (34). 
Revision of the negative CT scans in cases with positive 
findings with lymphography showed, that in most instances 
the size of individual lymph nodes was within the usual 
limits, but that a local concentration of such clearly 
visible, unenlarged nodes should have aroused suspicion. 
Two out of the total of 27 patients (= 7%) undergoing 
staging laparotomy were excluded from evaluation because 
the radiologically suspect nodes were not biopsied. 
Although surgical staging is the final step to complete 
pathological staging, it should be realized that non-
representative lymph-node sampling is a realistic problem 
occurring in about 10% of patients, even in very 
experienced hands (1,13,20,30). Intra-operative radiologic 
monitoring is apparently not able to reduce these sampling 
errors sufficiently. 
The advantage of CT over lymphography by visualizing all 
abdominal lymph-node regions including the spleen is not 
to be translated in a more accurate staging potential 
(table II). Mesenteric lymph-node involvement is only 
occasionally the sole intra-abdominal finding (1). When 
present, the retroperitoneal nodes are mostly widely 
involved. The high para-aortic nodes are more often 
involved, but the size of these nodes is usually within 
normal limits when they are the only intra-abdominal 
finding. 
Table II shows the radiologic findings related to 
laparotomy findings in various ways. Although the series 
is rather small, some speculative data can be distilled 
from it. Lymphography gives the best results when findings 
in the visualized lymph-node areas only are evaluated. 
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When non-visualized lymph-node areas are included, the 
accuracy rate drops due to a decreased sensitivity rate. 
The figures remain still slightly more favourable 
compared with the performance of CT with regard to the 
lymph nodes (all regions). The combined use of CT and 
lymphography in staging the abdominal lymph nodes improves 
minimally on the performance of lymphography only. 
Anatomic substaging of stage III HD gives relevant 
clinical and prognostic information (35). Stage ІІІ1 
includes involvement of spleen, or splenic, celiac or 
portal nodes or a combination of these. Stage III2 disease 
includes involvement of para-aortic, iliac or mesenteric 
nodes, with or without upper abdominal involvement. The 
former stage is associated with a better prognosis than 
the latter, and substaging results in different 
therapeutic regimens. Although CT and lymphography are 
relatively reliable in diagnosing stage III2 disease, 
stage Uli disease is subject to the insufficiencies of 
the methods as illustrated above. Three patients with 
stage Uli disease in our series (2 patients with spleen 
and lymph-node involvement, 1 patient with spleen 
involvement only) were not correctly identified, but 1 
patient with histologically proven spleen localization as 
the only pathological finding, was discovered by CT. 
Traditionally staging laparotomy has its greatest yield in 
revealing unexpected upper abdominal localization of 
disease, and will still be indicated when this information 
will modify the therapeutic strategy. 
Retrocrural^ lymph nodes^: 
The retrocrural area is in fact the most inferior 
extension of the posterior mediastinum. When enlarged 
retrocrural lymph nodes are diagnosed with CT, there is a 
high probability of upper mediastinal involvement: 6 of 
our 8 patients with enlarged retrocrural nodes showed 
evidence of upper thoracic lymph-node enlargement. 
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Fourteen patients showed the combination of abnormal chest 
X-ray findings and enlarged infradiaphragmatic nodes: 6 of 
these (=43%) had enlarged retrocrural nodes. Fourteen 
patients had normal chest findings associated with 
infradiaphragmatic lymph-node involvement, and retrocrural 
nodes were found in 1 case (=7%). Only 1 case of enlarged 
retrocrural nodes in association with normal abdominal 
nodes was seen. This was a patient with recurrent disease, 
who had undergone abdominal lymph-node irradiation in the 
past. The detection of enlarged retrocrural nodes during 
abdominal CT scanning is therefore highly suggestive of 
upper mediastinal lymph-node involvement. 
CONCLUSIONS 
1. Literature data correlating radiologic and histologic 
findings in patients, examined for HD, uniformly show a 
lower diagnostic accuracy of CT in comparison with 
lymphography. This difference is caused by a lower 
sensitivity of CT and an equal specificity. 
2. The above-mentioned conclusion also follows from the 
present study in 78 patients with HD. CT and 
lymphography disagreed in 18% of patients. When CT 
preceded lymphography the disagreement was 26%. When CT 
followed lymphography, the disagreement was 10%. 
Fifty percent of discordant findings consisted of a 
normal CT scan in combination with an abnormal 
lymphogram. In most of these cases, CT was carried out 
first. 
3. When CT is performed as the first investigation, 
lymphography will only yield significant information 
when CT is normal or equivocal. 
4. When lymphography is performed first, subsequent CT 
will only occasionally add significant information with 
regard to the lymph nodes. 
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ABSTRACT 
Findings of CT of the spleen were compared with those of 
histologic examination in 35 patients who had Hodgkin 
disease. CT provides a simple way to calculate splenic 
size. This index is also of value in the assessment of the 
histologic state of the spleen. An accuracy rate of 91%, 
specificity of 94%, and a sensitivity of 89% in diagnosing 
splenic localization of lymphoma was found in this study. 
INTRODUCTION 
In staging Hodgkin disease, the spleen has always been 
difficult to evaluate for the presence or absence of 
disease using non-invasive methods. Histologic examination 
following surgical removal of the spleen reveals a 
considerable number of pathologic findings in patients who 
have clinically occult disease. 
With the introduction of body CT, it was hoped that a more 
accurate preoperative diagnosis would be possible. Whereas 
the value of CT in demonstrating abdominal lymph node 
involvement has been established, most published series 
until now show rather disappointing results in the 
assessment of the histologic state of the spleen. 
Some pertinent radiologic, surgical, and pathologic-
anatomic findings in the literature and in own patients 
were analyzed to determine the role of CT in investigating 
the spleen in patients who have Hodgkin disease. 
MATERIAL AND METHODS 
A comparison was made of CT and histologic findings in the 
spleens of 35 patients who had Hodgkin disease (HD). 
Findings for 27 patients were evaluated retrospectively 
and for eight patients prospectively. In 25 of the 
patients who had previously untreated HD, which was 
clinically staged IIA or IIIA, a staging laparotomy was 
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performed. Of these, three patients presenting with infra-
diaphragmatic disease underwent laparotomy for both 
diagnostic and staging purposes. 
In seven patients in whom recurrent disease was suspected, 
laparotomy with splenectomy and sampling of abdominal 
nodes was performed. Three patients died shortly after 
clinical evaluation for recurrent disease, and in these 
patients CT was correlated with autopsy findings. 
In 26 patients, CT of the body was performed using an OHIO 
Nuclear 50 FS Delta Scanner with a scanning time of 18 
seconds and a section thickness of 13.5 mm. Contiguous 
scanning of the whole abdomen was performed with the scans 
of the upper abdomen in suspended expiration. Five 
patients were examined using a Siemens Somatom DR 3 with a 
scanning time of 5 seconds, and a section thickness of 8 
mm at 16 mm intervals. Four patients who had a CT 
examination elsewhere were referred. 
Intravenous contrast material was not administered 
routinely. CT criteria for splenic involvement with 
lymphoma are splenomegaly and/or the presence of low-
attenuation nodules. While there is general agreement that 
only nodules larger than 1 cm can be demonstrated with CT 
(1-6), the definition of splenomegaly is not uniform in 
the radiologic literature. Different criteria are applied 
by authors presenting CT-pathologic correlation in 
examination of the spleen (1-4,7,8). In the literature, 
the use of the splenic index as proposed by Lackner (3) 
offered the most practical definition of splenic size. We 
therefore calculated in review the splenic index in our 
patients, and applied the same calculation for the 
patients in the prospective study. The index is obtained 
by multiplying spleen thickness, width, and length as 
visualized on CT. The length is determined by adding all 
section-thicknesses (and intervals if used) on which the 
spleen is seen. The width is the longest (straight) organ 
diameter in the transverse (scanning) plane. The thickness 
is the distance between the center (inner) and peripheral 
(outer) surface, measured at the level of the splenic 
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hilum. When significant differences exist between anterior 
and posterior parts of the spleen, the mean value is taken 
(Fig. 1). 
Figure 1: 
Measurement of spleen diroensions in various spleen shapes (tracings 
from СГ sections). 
a. Width = longest transverse diameter, regardless of scan height 
through spleen or spleen orientation. 
b. Ihickness = distance from inner to outer surface, directly 
measured or mean value in cases with marked spleen asymmetry. 
Lackner found values ranging from 120-480 for normal 
spleens. In our study we used these values to discriminate 
between normal and diseased spleens on CT. Furthermore, 
the spleens were evaluated for the presence of hypodense 
nodules. The weight of the spleen, as recorded immediately 
after removal at surgery, was noted. 
To determine the histopathologic state of the spleen, the 
excised specimen was cut in slices of 0.5 cm thickness and 
inspected for macroscopic evidence of tumor localization. 
If present, tumor nodules were excised and 4 л. sections of 
the paraffin-embedded tissue blocks were studied 
microscopically. From macroscopically uninvolved spleens, 
at least five tissue blocks were taken from different 
areas. When no tumor could be demonstrated in sections of 
these blocks, the spleen was reported as pathologically 
negative. The histologic state of the liver was determined 
by examination of needle and wedge biopsy specimens 
obtained at laparotomy from both the left and right lobes, 
and from any grossly suspect area. 
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RESULTS 
Twenty-three patients were male (aged 16-62 years) and 12 
were female (aged 16-64 years). The most common histologic 
subtype was nodular sclerosis (n = 20), followed by 
lymphocyte depletion (n = 6), lymphocyte predominance 
(n = 4) and mixed cellularity (n = 3) HD. Two cases were 
unclassified. Laparotomy or autopsy was performed within a 
month after CT in 21 of 32 patients. The maximum interval 
was five months. The spleen was histologically positive 
for HD in 19 patients (54%) and negative in 16 (46%). The 
weight of 14 histologically negative spleens varied from 
74-320 g (mean weight 190 g) . The splenic index in this 
group varied from 153-690 (mean index 348). The weight of 
17 histologically positive spleens varied from 103-1,687 g 
(mean weight 545 g). The splenic index in this group 
varied from 194-2,483 (mean index 1,010). When comparing 
the sum of indices with the sum of weights, it was 
calculated that the average spleen weight (in grams) was 
0.55 χ splenic index. In 20 of 31 patients (65%) the 
difference between calculated and actual weight was less 
than 25%, and in 27 of 31 patients (87%) the difference 
was less than 35%. However, these figures are biased by 
the fact that in this predominantly retrospective study 
the process of weight determination and the time interval 
between CT and laparotomy or autopsy were of course not 
strictly standardized. 
Table I specifies the data concerning splenic index 
calculation in 27 patients studied retrospectively, in 
8 patients studied prospectively, and the results in the 
total group of 35 patients. 
Using the splenic index as an indicator of splenic 
involvement with lymphoma, it was found that 17 of 19 
involved spleens had a splenic index over 480 (sensitivity 
89%). Fifteen of 16 histologically uninvolved spleens had 
a splenic index lower than 480 (specificity 94%). The 
overall accuracy of the procedure therefore amounts to 
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32/35 (91%). These results are statistically significant 
(P < .001 using the ^2_ t e st with Yates correction). In 
only one of the spleens were low-attenuation areas visible 
on CT. Macroscopic findings of the operative specimens as 
registered in 14 histologically positive spleens revealed 
that nodules were visible in all these spleens, but only 
in five were nodules larger that 1 cm present. No nodules 
were visible in spleens that proved to be negative by 
histologic examination. The incidence of concurrent 
splenic and hepatic involvement with lymphoma is specified 
in table II. Hepatic involvement was not demonstrated in 
the absence of splenic involvement. The incidence of 
splenic and hepatic involvement in the various subtypes of 
HD is specified in table III. 
Table I; Correlation of CT-splenic Index Calculation. 
a)* 
b)* 
c)* 
СГ 
-
+ 
Total 
CT 
-
+ 
Total 
CT 
-
+ 
Total 
Histology 
Histology 
Histology 
-
11 
1 
12 
— 
4 
0 
4 
— 
15 
1 
16 
+ 
1 
14 
15 
+ 
1 
3 
4 
+ 
2 
17 
19 
Total 
12 
15 
27 
Total 
5 
3 
θ 
Total 
17 
18 
35 
ace. 
sens. 
spec. 
=32/35
 ( 9 1 % ) 
= Vl9 (89%) 
= 15/16 (94%) 
*a) 27 patients studied retrospectively, and b) 8 patients studied 
prospectively; c) results of the combined groups. 
Ace. = accuracy (percentage of correct diagnoses). Sens.= 
sensitivity (percentage of patients with histologically positive 
spleens in which СГ findings were correctly interpreted as 
positive), Spec. = specificity (percentage of patients with 
histologically normal spleens in which СГ findings were correctly 
interpreted as negative). 
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Table II; Conparison of Liver and Spleen Histology 
in 34 patients.* 
Liver 
+ 
-
Total 
Spleen + 
8 
10 
18 
-
0 
16 
16 
Total 
8 
26 
34 
* Hodgkin disease present (+) 
or absent (-) histologically. 
Table III; Spleen and liver involvanent in 33 patients according to 
HD-subtype. 
Subtype 
Nodular sclerosing 
Lymphocyte depleted 
Lymphocyte predominant 
Mixed cellular 
Total 
No. 
20 
6 
4 
3 
33 
spleen 
+ 
12 8 
0 6 
1 3 
1 2 
14 19 
liver and spleen 
involvement 
2 
3 
1 
2 
8 
Splenic weight (g) 
1500-
1000 
500 
weight unknown о о 
500 1000 1500 2000 2500 
Splenic index 
Figure 2; Correlation of splenic weight and splenic index of spleens 
positive (·) or negative (o) at histologic exanination; 
splenic index of 480 as upper limit of normal range. 
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DISCUSSION 
Laparotomy with splenectomy reveals clinically unsuspected 
areas of disease in 23-30% of patients who have Hodgkin 
disease (7,9-15). An advanced clinical stage, the presence 
of B-symptoms (9-11,13,16), and the mixed cellular 
histological subtype (9,10) are associated with an 
increased incidence of splenic involvement. However, 
conventional non-invasive diagnostic procedures are 
unreliable to assess eventual presence of disease in the 
spleen (9,12,13,16-18). 
With the introduction of CT it became possible to 
visualize the size and internal structure of the spleen. 
However, reported series until now show rather 
disappointing results in demonstrating or excluding 
splenic involvement with lymphoma (1-8, 19-21). 
Involvement of the spleen with lymphoma is nearly always 
visible macroscopically. The pathologist rarely finds 
lymphoma at histologic examination of a grossly normal 
looking spleen (2,6,9). This is confirmed by the present 
study. Usually, however, the size of most nodules is too 
small to be detectable by current CT techniques. Only 
nodules larger than 1 cm may become visible as low 
attenuation areas (1,2,4,5). Although intravenous contrast 
medium has not been used consistently in this or previous 
series, the beneficial effect of this procedure is 
doubtful (6). In fact, a recent report demonstrates that 
even in normal spleens an irregular contrast enhancement 
is not rarely observed after intravenous injection (22). 
This finding corroborates a previous report by Castellino 
et al. who employed splenic arteriography in patients who 
had HD (23). The efficacy of newly developed contrast 
media for specific enhancement of liver and splenic tissue 
is demonstrated (24) but their clinical use is not yet 
generally accepted. 
The limited value of CT in detecting splenic tumor nodules 
is emphasized by this study, since only five of 14 
histologically positive spleens contained nodules with a 
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diameter larger than 1 cm, and only one of these was 
detected with CT. 
The most important parameter for clinical diagnosis of 
splenic involvement with lymphoma (HD or non-Hodgkin 
lymphoma) is enlargement of the spleen. However, 
evaluation of splenic size by palpation has proved to be 
rather unreliable, with 0-25% falsely positive diagnoses 
and 60-94% falsely negative diagnoses (9,12,13,16,18,25, 
26). Moreover, an involved spleen is often found to be of 
normal size, whereas definite splenic enlargement occurs 
without histological evidence of disease (9,12,13,27,28). 
No strict correlation between the weight of an operative 
specimen and its histopathologic state has been 
established (9,12,13,17,25,26). As weight and size of an 
excised spleen are partially determined by the amount of 
entrapped blood, a variable bias is introduced by 
circulatory factors during operation, timing of vessel 
clamping, and uncontrolled loss of blood from the specimen 
before it is weighed. 
Correlation between weight and histology therefore 
appeared to be less valid. Only a weight of over 400 g was 
found to be consistently associated with localization of 
lymphoma (9,16). In this series a marked discrepancy 
between weight and size as estimated by CT was sometimes 
recorded (fig. 2). The time lag between CT and laparotomy 
was not responsible for these differences. 
A reliable determination of size and volume by means of CT 
is possible in vivo (29-31). However, most previous 
studies estimated splenic size in patients who had 
malignant lymphoma by employing crude criteria. Blackledge 
and Best et al. (4,7) diagnose splenomegaly when the organ 
extends below the ribs. Ellert and Kreel (8) diagnose 
enlargement when the spleen extends more than two thirds 
the distance between the posterior and anterior abdominal 
walls. The consequence of using incomplete or inexact 
criteria is a low accuracy rate associated with a high 
specificity (i.e., few false positives) and a low 
sensitivity (i.e., numerous false negatives) (fig. 3). 
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Accuracy (Vo) 
• <70 
A 70-79 
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• 90-100 
D present series 
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, „ . .„ 2 19 6721 4 5 20 100-f »i 1 1 , ? 1 1—IT, «• r* 1 -
100 80 60 40 20 0 
Sensitivity (%) 
Fig. 3: Correlation of sensitivity and specificity as calculated 
frcm literature data on CT-pathologic correlation of the 
spleen. Njmbers in accordance with bibliography. 
When applying the receiver operating characteristic (ROC) 
concept (32) to these results, it is suggested that 
improvement in sensitivity without a marked loss in 
specificity should be possible by a more accurate 
definition of splenic size. Both series in which all three 
dimensions (length, width, and thickness) were measured on 
CT scans, have high accuracy rates with few falsely 
positive or falsely negative diagnoses (2,3). 
Lackner et al. (3) introduced the term "splenic index" for 
the product of spleen thickness χ width χ length. This 
parameter appeared to be a reliable indicator of splenic 
size and involvement in his series. In 100 patients who 
did not have disease related to the spleen he found a 
maximum value of 480. In 11 patients who had malignant 
lymphoma, four spleens had an index well above 500, and 
all these spleens were histologically positive for 
lymphoma. The other seven spleens had an index below 500 
and proved to be negative. In our patients, the original 
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CT reports were 71% accurate with regard to determination 
of splenic involvement. In review, using a splenic index 
of 480 as threshold value, the accuracy increased to 91%. 
As shown in figure 2, there appears to be a linear 
relationship between splenic weight and index. It is 
suggested that the splenic index can serve as an indicator 
for splenic weight in vivo. Splenic weight in grains 
amounts to approximately 0.55 χ splenic index. The 
proposed range for normal spleens of 120 to 480 according 
to Lackner, would correspond to a weight range of 65 to 
265 g. One falsely negative spleen in our series had an 
index of 194 and a weight of 103 g (case 6). Macroscopic 
examination revealed two tumor nodules smaller than 1cm. 
At microscopic examination, a multifocal spread of Hodgkin 
disease was present. Another falsely negative spleen 
weighed 195 g with a splenic index of 286. Histologically, 
several nodules smaller than 6 mm were visible. The only 
falsely positive spleen on CT in our series had an index 
of 690 and weighed 320 g (case 9). Histologic examination 
revealed signs of chronic congestion but no evidence of 
lymphoma. 
An obvious advantage of using the splenic index rather 
than splenic weight as indicator of disease is that 
calculation of splenic index is an in vivo measurement, 
leaving the patient untouched and intact. It is 
conceivable that the diagnostic significance of the 
splenic index will be less reliable when this index 
approaches the threshold value of 480. When confirming 
data from the older literature that states that only 
spleens heavier that 400 g are consistently involved with 
lymphoma (9,16), one can increase the threshold value to 
725. This implies a decreased sensitivity for the method, 
but fewer false positive CT diagnoses. For the present 
study this altered criterion would lead to an overall 
accuracy of 27/35 (77%), a sensitivity of 11/19 (57%), and 
a specificity of 16/16 (100%) (table IV). 
The histologic findings in the liver in our patients 
confirm the earlier observations that liver involvement in 
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Table В/: Infloence of increasing the threshold value from 480 to 
725 with regard to diagnostic accuracy.* 
Histology - + Total 
CT 
16 8 24 
+ 0 11 11 
Total 16 19 35 
* See text; conpare with table Ic. 
Hodgkin disease does not occur in the absence of splenic 
involvement (9,12,17,18). Conversely, in one patient (not 
included in this study) in whom positive findings of liver 
biopsy were obtained, an elevated splenic index of 732 was 
measured. 
Although the number of patients in our series compares 
favorably with other series in the literature (1-3,6,8, 
19-21), the validity of the splenic index as indicator of 
size and disease in the spleen in patients with HD will 
have to be tested in larger, prospective studies. 
Calculation of total splenic volume, as is possible with 
CT (29-31) will probably give an even more exact approach 
to the determination of splenic size. 
CONCLUSION 
CT is a reliable technique for visualizing size, shape, 
and structure of organs in vivo. In reviewing the 
literature and after evaluation of our patient material, 
it is suggested that the accuracy of diagnosing 
involvement of the spleen with HD can be improved by a 
more exact definition of splenic size using the splenic 
index. In 35 patients who had HD, a diagnostic accuracy of 
91% was obtained with a falsely positive rate of 6% and a 
falsely negative rate of 11%. Application of this 
criterion, or the calculation of total splenic volume with 
CT, could increase the sensitivity of this technique that 
already has demonstrated a high specificity in the 
visualization of splenic and abdominal lymphoma. 
accuracy = 27/3 5 (77%) 
sensitivity = 11/i9 (57%) 
specificity = 1б/іб (100%) 
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CRITICAL REVIEW 
Investigative Radiology 1986; 21: 437-439 
Albert A. Moss, MD, editor 
This section of the journal is designed to present 
constructive comments on investigations which are reported 
in the world literature and which are within the scope of 
Investigative Radiology. In each case the authors of the 
original articles are given the opportunity to respond to 
the comments of the reviewers. The readers of the 
Investigative Radiology are invited to take part in the 
open exchange of opinions through Letters to the Editor. 
The Spleen in Hodgkin Disease : Diagnostic Value of CT 
Authors: S.P. Strijk, D.J. Wagener, M.J.J.T. Bogman, B.E. 
de Pauw, and T. Wobbes. 
Publication: Radiology 1985; 154: 753-757. 
SUMMARY OF THE ARTICLE 
The authors correlate their estimates of splenic volumes, 
based on CT measurements, with the results of histologic 
examination of the spleen (staging laparotomy in 25 cases, 
laparotomy to establish recurrent disease in seven cases, 
and autopsy in three cases) from patients with Hodgkin's 
disease. They conclude that the CT-derived splenic volume 
(the "splenic index") is useful in assessing the 
histologic status of the spleen. 
REVIEWERS' COMMENTS 
This conclusion is made despite well-documented studies on 
Hodgkin's disease from numerous investigators indicating 
that the splenic weight (as determined at staging 
laparotomy) is a poor predictor of splenic histopathology. 
The authors contend that correlations of histology and the 
actual weight of the resected spleen are less valid than 
correlation of histology and the CT-derived volume 
("splenic index"). They argue that variables are 
introduced by circulatory factors during surgery, timing 
of vessel clamping, and uncontrolled loss of blood from 
the spleen before weighing. This is an interesting 
concept, although the study does not address this specific 
point. 
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Given the current understanding of the histopathology of 
Hodgkin's disease involvement of the spleen, one would not 
expect a significant correlation between the splenic size 
(volume) or weight and the histopathologic examination, 
unless the organ is extensively involved with tumor (in 
which case such splenomegaly is readily detected by 
palpation, abdominal films, etc.). In patients with 
previously untreated disease, splenic lesions are often 
focal, nodular, and less than 1 cm in size. There is 
little to no surrounding edema or cellular infiltrate to 
add bulk to the spleen to produce significant changes in 
either weight or size (volume). Conversely, in patients 
with Hodgkin's disease, large spleens may not contain 
histopathologic evidence of tumor. 
To test the authors' conclusions, we retrospectively 
reviewed the CT scans of 24 randomly chosen patients with 
previously untreated Hodgkin's disease who had CT scans 
followed by staging laparotomy and splenectomy. The CT 
scans were reviewed in a blind fashion (T.G.) and the 
"splenic index" was calculated according to the method 
described by Strijk et al. 
Of the 24 cases we reviewed, 20 patients had nodular 
sclerosing Hodgkin's disease, 3 mixed cellularity 
Hodgkin's disease, and 1 lymphocyte depletion Hodgkin's 
disease. Ten of 24 (42%) patients had histologically 
positive spleens. The CT-derived "splenic index" (more 
than 480 being abnormal) showed an accuracy of 54% (13 of 
24), a sensitivity of 30% (three of ten), and a 
specificity of 71% (ten of 14) in assessing the spleen. 
The weight of the resected spleen (more than 250 gm being 
abnormal) showed an accuracy of 58% (14 of 24), a 
sensitivity of 20% (two of ten), and a specificity of 86% 
(12 of 14). Neither a positive CT "splenic index" nor the 
weight of the resected spleen showed a strong correlation 
with a positive histopathologic examination (P>.05 using 
the χ2 test with Yates correction). In our patients, the 
splenic weights averaged 36% of the "splenic indices," 
whereas Strijk et al. noted a ratio of 55%. It is 
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provocative to note that our largest measured spleen, with 
a "splenic index" of 1260 and a weight of 410 gm, on 
careful sectioning showed only two nodules of tumor, each 
measuring less than 1 cm, contributing approximately only 
2 gm to the weight of the spleen. 
Some aspects of the authors' study design could provide 
misleading information. 
* Their calculations of splenic volumes and subsequent 
comparison with the histologic results were made 
retrospectively in 27 cases and prospectively in only 
eight cases. No reference is made to whether there was 
preliminary knowledge of the histologic results prior to 
review of the CT scans from those 27 patients examined 
retrospectively. 
* The time between CT and histologic examination of the 
spleen was less than one month in 21 patients, and 
ranged up to five months in the rest. This long time 
interval precludes careful correlation of the CT data 
with the splenectomy specimen in a substantial number of 
cases. 
* The presented data are incomplete, presumably due to the 
retrospective nature of the study. Thus, in four cases 
no splenic weight was recorded and in five of 19 
histologically positive cases, the size of splenic 
lesions was not noted. 
* The authors studied a nonhomogeneous patient population. 
Previously untreated Hodgkin's disease was newly 
diagnosed in 25 patients; 10 patients were evaluated for 
recurrent disease. This inclusion of patients with 
recurrent disease presumably accounts for the extremely 
large weights of several spleens, four of which measured 
over 1,000 gms, which is unusual in patients with 
untreated disease. The very high incidence of positive 
livers (eight of 34, or 24%) probably is explained by 
the inclusion of patients suffering relapse. 
* The authors do not specify whether they used a 
consecutive patient population or if patients were 
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selected for this study. The percentage of their 
patients with histologic proof of splenic involvement 
(54%) is higher than the 38% noted by Kaplan (1) for Θ14 
consecutive, unselected, previously untreated patients 
with Hodgkin's disease undergoing laparotomy and 
splenectomy at Stanford. Their higher incidence of 
splenic disease may be related to the inclusion of 
patients with recurrent disease in their series or may 
reflect a bias in patient selection. 
Thus, the data that the authors present, showing a high 
degree of accuracy, sensitivity, and specificity (91%, 
89%, and 94%, respectively) in correlating the CT "splenic 
index" with involvement of the spleen with Hodgkin's 
disease, bear uncertain significance with respect to the 
preoperative evaluation and staging of untreated 
patients. Perhaps the greatest error was not presenting 
the data derived from the 25 patients undergoing initial 
staging CT studies separately from those of the ten who 
had relapsing disease. The excessively long time intervals 
between the CT scan and histologic evaluation of the 
spleen in many cases is also disquieting. 
In summary, there is little evidence to support the 
contention that spleen volume increases with early 
involvement by Hodgkin's disease. The authors' results of 
very high accuracy rates may be related to the design of 
the clinical experiment, as noted above. Using their 
criteria, we were unable to reproduce their high accuracy 
data in a group of 24 newly diagnosed patients. 
Thomas Gilbert, MD 
Ronald A. Castellino, MD 
Stanford University Medical Center 
Stanford, California 
Reference 
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AUTHORS' RESPONSE 
The fact that although CT has the potential for exact 
volume determinations in vivo, most series evaluating the 
spleen in patients with malignant lymphoma use criteria 
that yield diagnostic results of low accuracy and 
sensitivity, but of very high specificity, stimulated us 
to test the efficacy of better defined criteria. We are 
aware of the numerous publications in which splenic weight 
correlated poorly with spleen histology. There are some 
indications that the weight of an operatively obtained 
specimen may not reflect actual spleen size in vivo. 
Spleen size varies with respiration; Jahnke found 
differences of up to 9% between inspiratory and expiratory 
values in the same patient during the same investigation 
(1). Spleen size diminishes in reaction to intravenously 
administered epinephrine - Rosen found that size decreased 
up to 35% in normal controls, and up to 10% in a patient 
with Hodgkin's disease (2). Intraoperative spleen handling 
resulting in occlusion of arterial and venous flow also 
may induce uncontrollable deviations from the baseline 
flow (and blood content) of the untouched organ. Labrie 
determined the weight of the spleen, both in the operating 
room and in the pathology laboratory in 17 patients with 
Hodgkin's disease undergoing splenectomy. He established a 
mean difference of 40 gm (range, 10 to 110 gm), caused by 
the loss of blood from the specimen (3). 
These observations led us to the hypothesis that the size 
of the organ in the intact patient might correlate better 
with the histopathologic state than the weight of the 
specimen after removal. 
In response to the remarks of the reviewers, we have 
rearranged our original data, and we summarize the results 
here. 
In ten patients, staged for recurrent disease, the spleen 
was involved in eight cases (five patients also had 
histologically demonstrated localization in the liver). 
Splenic index calculation in this group proved to have an 
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accuracy rate of 100%. In 25 patients with previously 
untreated disease, the spleen was histologically involved 
in 11 cases (44%, similar to the reviewers' series). 
Splenic index calculation showed an accuracy of 88% with a 
sensitivity of 82% and a specificity of 93%. These figures 
are slightly less favorable than the overall results in 
the 35 patients (91%, 89%, and 94% respectively). 
Laparotomy was performed within one month in 16 of 21 
patients (76%). The liver was involved in three of 25 
patients (12%). Five patients were studied prospectively, 
and in many of the remaining patients the spleen histology 
was known at the time of review. 
Patients were included in this study based on a CT scan 
prior to laparotomy, and did not receive systemic therapy 
in the meantime. Several other patients underwent 
laparotomy without having a CT scan, apparently to avoid 
undue time delay caused by a limited scanning capacity. We 
conclude from their previous article (4) that differences 
between our diagnostic results and those of reviewers are 
probably not sufficiently explained by a difference in 
patient selection. The composition of the two groups 
differs. Our 25 patients with Hodgkin's disease include 
five patients with the lymphocyte depleted variety, all of 
whom had an involved spleen at histologic examination. 
All three diagnostic errors occurred in the group of 
patients with the nodular sclerosing variety that 
constituted 52% of the patients. 
In comparison, the reviewers' group contained 20 patients 
with this histologic type (83%). These factors also may 
contribute to the difference in diagnostic accuracy. 
In general, the validity of diagnostic tests is influenced 
by the way the data are obtained: we presented our study 
as a predominantly retrospective one with all known 
inherent deficiencies. 
Even prospective studies in a larger, apparently 
homogeneous group may seem to lack consistency. 
This can be illustrated by comparing the Stanford 
University data presented in 1983 and 1984 (4,5). Whereas 
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in 1983 (5) CT of the spleen in 87 patients still had a 
diagnostic accuracy of 68%, a specificity of 73%, and 
sensitivity of 61% (23 of 38 patients had a correctly 
positive CT diagnosis), the results in 1984 (4) on 121 
patients showed a diagnostic accuracy of 58% with a 
specificity of 76%, and a dramatically decreased 
sensitivity of 33% (17 of 51 patients with a correctly 
positive CT diagnosis). Because diagnostic criteria were 
apparently unchanged, this difference must have been the 
results of a significant change in composition of the 
patient groups. 
Our empirically derived formula for spleen weight 
estimation (weight = 0.55 к splenic index = 0.55 χ length 
χ width χ thickness) closely resembles the formula used 
for spleen volume estimation by scintigraphic and 
ultrasonographic methods (6-8) that are based on the 
assumption of an ellipsoid model for the spleen (volume = 
0.52 χ length χ short diameter χ long diameter). We cannot 
explain the fact that the reviewers found a correlation 
factor of 0.39. 
We are generating normal values for spleen size by splenic 
index calculation and volume calculating methods with CT 
(9,10). 
Preliminary data suggest that a splenic index value of 480 
is valuable in most patient groups, but that a higher 
upper limit threshold will have to be adopted for young 
men. Until these values become established, we continue to 
use our "old" values. 
Our article does not contend that spleen volume increases 
with early involvement in Hodgkin's disease. We present 
the results of a (predominantly) retrospective study, 
which suggest that a better definition of spleen size in 
vivo improves the diagnostic value of CT. We noted the 
need for a prospective study to evaluate our observations 
further. We do not propose an additional investigation in 
patients with Hodgkin's disease, but hope to derive more 
information from a radiologic examination that most 
patients already undergo. We present an easily applicable 
- 55 -
criterion for estimation of spleen size that can be 
adapted at will to find an acceptable balance between 
sensitivity and specificity. 
We are grateful to the reviewers for testing our method in 
a sample of their material. The fact that they could not 
reproduce our favorable results is neither unexpected nor 
discouraging. As more data become available, we may find 
that the criterion of CT-splenomegaly is only valuable 
under certain conditions, eg, in recurrent disease or with 
unfavorable histologies. 
Until then, we hope to extend our experience. 
Simon P. Strijk 
Department of Diagnostic Radiology 
St. Radboud Hospital 
The Netherlands 
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REVIEWERS' REPLY 
We thank the authors for responding to our review by 
reanalyzing their orginal data per our suggestion. This 
reanalysis confirms our impression that (1) when the 
spleen is involved with recurrent disease, the degree of 
involvement is more extensive than at initial 
presentation, (2) increased splenic size might show a 
significant correlation with histologically-proven disease 
in the setting of disease relapse, (3) their study was 
biased by mixing these two patient populations, ie, those 
with newly diagnosed disease and those with relapsing 
disease. Few data are available, however, to assess the 
ability of a normal splenic size to rule out splenic 
disease in these patients. 
Our concerns remain - that the data, in the manner in 
which it was originally presented, might mislead the 
casual reader to believe the CT scan-derived estimates of 
splenic volume would be useful predictors of splenic 
disease in patients who present with Hodgkin's disease for 
initial staging. Given the far-reaching implications of 
these potential conclusions, we feel that additional 
attention should have been given to the study design, and 
even more importantly to the format in which the data was 
originally presented in the published article. 
T.J. Gilbert, MD 
R.A. Castellino, MD 
Stanford University Medical Center 
Stanford, California 
Chapter 4 
LYMPHOGRAPHY AND ABDOMINAL COMPUTED TOMOGRAPHY IN STAGING 
NON-HODGKIN LYMPHOMA. 
With an analysis of discrepancies. 
Simon P. Strijk 
Department of Diagnostic Radiology, 
University Hospital St. Radboud 
Nijmegen, The Netherlands. 
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ABSTRACT 
Ninety-one patients with non-Hodgkin lymphoma (NHL) were 
subjected to CT and lymphography. Both examinations agreed 
on 74 patients (81%) with regard to the infradiaphragmatic 
lymph nodes. In patients undergoing CT prior to 
lymphography, the concordance amounted to 75%. When 
lymphography was the initial examination, the concordance 
amounted to 86%. 
Lymphography was abnormal in 30% of patients with a normal 
CT scan and in 93% of patients with an abnormal CT scan as 
the first examination. CT was abnormal in 4% of patients 
with a normal lymphogram and in 84% of patients with an 
abnormal lymphogram as the first examination. 
CT did not detect mesenteric or retrocrural lymph-node 
enlargement in the absence of retroperitoneal lymph-node 
involvement. Eleven patients had extranodal manifestations 
of disease (excluding liver and spleen), and 3 were 
detected primarily with CT. Lymphography is the most 
complete examination for the infradiaphragmatic lymph 
nodes for staging purposes. Although CT outlined the 
disease better, it changed the lymphographic diagnosis in 
only 2 % of patients. Lymphography modified the CT-stage 
in 15% of patients. When abdominal CT is performed first 
in staging patients with NHL, lymphography will only yield 
additional information when CT is normal or equivocal. 
INTRODUCTION 
The diagnostic value of lymphography in patients with 
Hodgkin disease (HD) and non-Hodgkin lymphoma (NHL) has 
been established in numerous series. Ample correlation 
between radiologic and histologic findings in pelvic and 
retroperitoneal lymph nodes has been procured. Computed 
tomography (CT) is another imaging modality, which can not 
only visualize the same region of interest, but also 
offers the opportunity to evaluate other body regions. 
While in HD staging laparotomy is still regularly 
performed and provides histologic control of the 
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diagnostic methods, treatment strategies in patients with 
NHL are nowadays largely dictated by the histologic grade 
of malignancy of the specific type of lymphoma. By many 
institutions staging laparotomy is only indicated in 
selected cases, and this is the main reason why comparison 
of CT-findings with histologic data is not available now 
on such a large scale as in the earlier days of 
lymphography. As a result of this, the diagnostic value of 
CT in patients with NHL can mostly be related to the 
findings of lymphography and to the clinical course only. 
When both imaging methods are used in the same patient it 
may happen that the results of these examinations appear 
to be contradictory. In the present report lymphography 
and CT findings with a group of 91 patients having NHL are 
discussed, with an analysis of discrepancies. 
MATERIAL AND METHODS 
During the years 1978 to 1984, 91 patients with NHL 
underwent lymphography and abdominal CT as part of a 
staging procedure. Eighty-five patients were examined for 
primary, untreated disease and 6 patients were staged for 
recurrent disease. Sixty-two patients were male and 29 
were female. Ages ranged from 15 to 75 years in male 
patients (mean age 50 years) and from 16 to 74 years in 
female patients (mean age 51 years). 
Lymphography was performed using standard techniques, and 
was interpreted using generally accepted diagnostic 
criteria based on structure rather than size of the 
visualized nodes (5). 
CT was performed in 58 patients with an OHIO Nuclear 50 FS 
Delta Scan with a scanning time of 18 seconds and a slice 
thickness of 13.5 mm, and with contiguous scanning of the 
whole abdomen. In 29 patients scanning was performed with 
a Siemens Somatom DR 3 with a scanning time of 5 seconds 
and a slice thickness of 8 mm at 16 mm intervals. Four 
patients were referred with a CT scan made elsewhere. 
Diluted water-soluble contrast medium was administered 
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orally in all patients, but intravenous contrast medium 
injection was not routinely performed. The main CT 
criterion for diagnosing lymph-node abnormality was its 
size. Nodes with a diameter exceeding 1.5 cm were 
considered pathologic, and when smaller than 1 cm they 
were considered normal. Nodes with an intermediate size 
were regarded as equivocal, but when a group of nodes of 
this size was seen, this was considered to be suspect 
(7,13,15, 18,20). For retrocrural nodes, normal size was 
limited up to 6 mm (3, 13). The order of both investiga­
tions was arbitrarily in the early years, while in later 
years CT was carried out first when time schedule allowed. 
The original interpretations of the CT and the lymphogram 
were maintained in this study. Generally, interpretation 
of one examination was performed with knowledge of the 
result of the previous examination. 
Although CT visualizes more lymph-node regions than 
lymphography, the final overall conclusions of either 
report (positive, negative, equivocal) were compared, 
including the lymph-node regions that cannot be reached 
with lymphography. Cases with divergent conclusions were 
reviewed to define the area of discrepancy. The CT scans 
were reviewed for specification of the various lymph-
node regions involved (retroperitoneal, mesenteric, 
retrocrural). Organ involvement was noted and spleen size 
was calculated in retrospect using the splenic index. 
The splenic index (14,24) is calculated by multiplying 
spleen length, width, and thickness. Spleen length is the 
sum of all slice thicknesses (and intervals if used) on 
which the spleen can be seen. Spleen width and thickness 
are the largest (straight) organ diameters from anterior 
to posterior border, and from internal to external surface 
respectively. According to previous studies (14), an index 
of 4Θ0 is used as upper limit of what is considered 
normal. By definition, a higher index indicates 
splenomegaly, and is suspect for histologic involvement 
with lymphoma (23,24). Spleen histology was available with 
10 patienta (5 laparotomy, and 5 autopsy cases). 
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RESULTS 
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CT and lymphography were performed i n 91 p a t i e n t s w i t h a 
h i s t o l o g i c a l l y conf irmed d i a g n o s i s of NHL ( t a b l e 1 ) . The 
r e s u l t s of both e x a m i n a t i o n s were in agreement i n 74 
p a t i e n t s (= 81%). There was d i s a g r e e m e n t in 17 p a t i e n t s (= 
19%). The r e g i o n and c a u s e of d i s c r e p a n c y are s p e c i f i e d i n 
t a b l e 2 . 
Table 1 : Conparison of СГ and Ivnphography diagnosis in 91 p a t i e n t s . 
Overall concordance 'V91 = 8 1 % . ( ) = %. 
lympho­
graphy 
+ 
± 
total 
CT + 
35 (39) 
2 (2) 
37 (41) 
" 
8 (9) 
39 (43) 
1 (1) 
48 (53) 
* 
3 (3) 
3 (3) 
6 (6) 
total 
46 (51) 
44 (48) 
1 (1) 
91 (100) 
Table 2 : Summary of discrepancies in 17 patients with d i v e r g e n t CT 
and lymphographic diagnosis. 
CT 
lymphogr 
+ 
-
+ 
1 case: unfilled 
inguinal node 
1 case: enlarged 
celiac nodes 
-
2 cases: insuffi­
cient СГ scan 
6 cases: normal 
sized nodes 
± 
3 cases: border­
line sized nodes 
1 case: insuf­
ficient CT scan 
2 rases: border­
line sized nodes 
± 
1 case: inguinal 
node not included 
in CT scan 
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The largest group of discrepancies consisted of β patients 
(= 9%) in whom the CT scan was normal, but in whom the 
lymphogram was abnormal. In all these cases, lymphography 
revealed textural abnormalities in nodes of normal size 
(fig. 1,2). In 2 out of these 8 patients, histologic 
examination of lymph nodes from the involved region 
confirmed the lymphographic findings. In another patient, 
the marked decrease in size of the pathologic nodes during 
chemotherapy supported the lymphographic diagnosis. In 1 
patient progressive lymph-node enlargement occurred in the 
lymphographically involved area during radiotherapy of a 
nasopharynx mass, and this was regarded as a support for 
the lymphographic diagnosis. In 2 patients, the CT scan 
was insufficient due to motion-artifacts. 
The comparative findings of CT and lymphography were also 
correlated to the order in which the investigations were 
performed (table 3 a,b). 
When lymphography was performed as the initial examination 
there was a concordance of 86% with subsequent CT-
findings. When CT was the first examination performed the 
concordance with the subsequent lymphography amounted to 
75%. CT was performed as the first examination in 7 out of 
8 patients having a normal CT scan and an abnormal 
lymphogram. 
Table 3a : Conparison of CT and lymphography in 51 patients. 
Lymphography performed before CT. 
Concordance 4V51 - 86%. ( ) = %. 
CT + - * total 
lympho­
graphy 
+ 21 (41) 1 (2) 3 (6) 25 (49) 
1 (2) 23 (45) 1 (2) 25 (49) 
± 1 (2) 1 (2) 
total 22 (43) 25 (49) 4 (8) 51 (100) 
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Table 3b : Comparison of CT and lymphography i n 40 p a t i e n t s . 
СГ performed before lymphography. 
Concordance 3 0 / 4 0 = 75%. ( ) = %. 
CT 
lympho­
graphy 
+ 
1 
tota l 
+ 
14 (35) 
1 (3) 
15 (38) 
" 
7 (17) 
16 (40) 
23 (57) 
± 
2 (3) 
2 (5) 
t o t a l 
2 1 ( 5 2 ) 
19(48) 
4 0 ( 1 0 0 ) 
2^_Mesente£ic and re trocrurc i l lymph noáes 
Nine out of 91 p a t i e n t s (= 10%) were found t o have 
m e s e n t e r i c lymph-node en largement w i t h CT, and i n a l l 
t h e s e p a t i e n t s e i t h e r CT or lymphography was p o s i t i v e for 
r e t r o p e r i t o n e a l node i n v o l v e m e n t . 
Three out of 27 p a t i e n t s wi th a normal c h e s t X-ray and 
abdominal node invo lvement had r e t r o c r u r a l lymph-node 
enlargement (= 11%). E ight out of 14 p a t i e n t s w i t h an 
abnormal c h e s t X-ray and abdominal node invo lvement had 
e n l a r g e d r e t r o c r u r a l nodes (= 57%). No i n s t a n c e of 
r e t r o c r u r a l lymph-node en largement was d e t e c t e d i n t h e 
p r e s e n c e of normal abdominal f i n d i n g s . 
λ ' _
I
' i v £ r _ a i l < î _ s £ lË . e i l 
Splenic index calculation was used to estimate splenic 
size and served as an indicator for splenic involvement 
with lymphoma. The results are summarized in table 4. An 
enlarged spleen was more frequently seen in the presence 
of abnormal infradiaphragmatic nodes. 
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Table 4 : Correlation between splenic index (s.i.) and infra-
diaphragmatic lymph node status in 84 patients. 
s.i. 
<480 
>480 
total 
η 
54 
30 
84 
(%) 
(64) 
(36) 
(100) 
lymph 
normal 
31 (37) 
8 (10) 
39 (47) 
nodes 
abnormal 
23 (27) 
22 (26) 
45 (53) 
Spleen histology was available with 10 patients. The 
spleen was histologically normal in 5 patients, and 
involved with lymphoma in the remaining 5 cases. The 
diagnostic accuracy of splenic index calculation was 100%. 
Percutaneous liver biopsy was performed in 57 patients. In 
11 of them, localization of lymphoma was proven 
histologically. However, CT was suggestive in only 1 
patient (marked hepatomegaly), and inconspicuous in all 
other patients. 
4^_Inyolvement_of^ othe£ oraans_ 
Seven patients had gastro-intestinal localization of NHL. 
However, this diagnosis was made or suggested by physical 
examination, endoscopy, or Barium-examination prior to CT 
in all cases, and was in fact the first clinical 
manifestation of disease in 5 patients. In 2 of them, CT 
and lymphography were otherwise normal. 
Involvement of both kidneys, homolateral kidney and 
adrenal gland, lumbar spine and (female) genital system 
was discovered in 1 patient each. These patients also 
showed retroperitoneal lymph-node involvement with CT or 
lymphography. In addition, there were 2 patients with 
extra-abdominal skeletal involvement, and 1 patient with 
lymphoma of the cerebellum as the primary localization and 
manifestation of disease. 
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DISCUSSION 
The diagnostic accuracy of lymphography in malignant 
lymphoma (HD and NHL) varies between 69% and 95%, with a 
sensitivity of 85% to 100% and a specificity of 74% to 98% 
(2,4,6,7,14,16,17,25). The accuracy of CT is lower (62% to 
82%), with a specificity of 75% to 93% (equal to 
lymphography), but with a lower sensitivity of 65% to 86% 
(2,4,6,7,14,16,17,25). However, histologically verified CT 
studies in patients with NHL exclusively are scarce, due 
to the decreased number of staging laparotomies (21). 
The present study in 91 patients with NHL is also 
predominantly based on probability diagnoses with 
lymphography as the gold standard. Only 5 patients 
underwent laparotomy after initial staging. 
The concordance between lymphography and CT reports in the 
literature in patients with malignant lymphoma varies 
between 76% and 100%, with an average of 87% (1,9,12,14, 
15,20,22). Usually the discrepancies are explained by the 
fact that lymphography reveals textural abnormalities in 
nodes of normal or minimally increased size. In the 
present study a concordance between the CT and 
lymphography report was found in 81% of cases. As expected 
most discrepancies consisted of a normal or equivocal CT 
scan in combination with an abnormal lymphogram (table 
1,2 - fig. 1,2). 
In retrospect most of the abnormal lymph nodes seen by 
lymphography were identifiable on the CT scan, but they 
were usually not or only minimally enlarged. 
There was a striking difference when the discrepancies 
were related to the order of the examinations. When 
lymphography had been performed first, the subsequent CT 
scan was false-negative in only 1 out of 25 patients 
(4%). Conversely the subsequent lymphogram was abnormal in 
7 out of 23 patients (30%) with a normal CT scan as the 
first investigation. These discrepancies were 
proportionally divided between the slower and the faster 
scanner, and were therefore not exclusively related to 
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technical factors: motion-artifacts due to the longer 
exposure time with the slower scanner was the 
incriminating factor in 2 patients. 
The difference in concordance between CT and lymphography 
in relation to the sequence of investigations is probably 
related to the fact that in our clinical setting the 
result of the first examination is generally known to the 
radiologist performing the second examination. It 
apparently occurs that during the interpretation of an 
abdominal CT, the final conclusion of the preceding 
lymphography is adopted. Another factor contributing to 
the high yield of lymphographic abnormalities in patients 
with a normal CT scan might be that only patients with a 
high index of suspicion and with an as yet unconfirmed 
generalized disease were selected for lymphography. 
However, due to the retrospective character of this study, 
this hypothesis could not be verified. The assumption that 
the lymphographic diagnosis was correct in these 7 
patients, was proven histologically in 2 patients. In the 
remaining 5 patients the characteristic lymphographic 
appearance of the nodes in conjunction with clinical data 
and follow-up made the lymphographic diagnosis probable. 
Our data imply, that - when both imaging techniques are 
compared for their diagnostic value - it is not only 
necessary to interpret the examinations independently, but 
also to specify the order of the examinations, and the 
awareness of the results of the first examination. 
CT discovered abnormalities in infradiaphragmatic nodes in 
2 out of 44 patients (5%) with a normal lymphogram. In one 
of these patients, the discrepancy was caused by the 
presence of an enlarged inguinal node, which had not 
stored contrast medium after lymphography. This node was 
palpable on physical examination. In the second patient, 
who had NHL· of the stomach, CT visualized enlarged nodes 
around the celiac axis, outside the scope of the 
lymphogram. The other nodes were normal with both 
methods. CT and lymphography in these 2 patients were 
therefore not contradictory, but complementary. CT reports 
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Fig. Is Left-sided para-aortic nodes (arrows) of 1 an diameter, 
interpreted with СГ as normal (la). 
Lymphography demonstrates lymphonatous appearance (lb). 
Fig. 2: Left-sided inguinal nodes (arrows) of 13 mm diameter, with 
CT interpreted as normal (2a). 
Lymphomatous appearance at lymphography (2b). 
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that appeared to be false-positive when compared with 
lymphography reports were not met. Two patients in whom CT 
was performed first had equivocal reports: one due to 
inadequate scanning technique, and one due to the presence 
of borderline-sized nodes. Subsequent lymphography was 
normal in both cases. 
Contrast medium in lymph nodes causes an increase in size 
of the nodes. When CT is performed after lymphography, 
lymph-node size should therefore be interpreted carefully 
because the actual size of nodes can be overestimated. 
This may lead to equivocal or false-positive 
interpretations. This phenomenon may explain that CT was 
interpreted to be equivocal due to borderline lymph-node 
enlargement in a patient with lympographically normal 
nodes. In 3 other patients CT was equivocal after a 
positive lymphogram, and in all these cases the nodes were 
likewise not or minimally enlarged with lymphography 
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The relatively large number of equivocal CT-diagnoses was 
acceptable in our clinical setting, because most patients 
had or would have a lymphogram, after which a definitive 
(clinical) staging diagnosis was made. With increasing 
experience, and improvement of scanning technique, the 
confidence in the CT-diagnosis also increased, and 
lymphography was gradually less frequently performed. It 
is realized that CT cannot visualize minimal disease in 
lymph nodes, but many patients with NHL are scheduled for 
systemic treatment anyway. At present, lymphography in 
patients with NHL is only performed in our hospital when 
CT is normal or equivocal, and when the information 
obtained could lead to a change in treatment strategy. 
Staging laparotomy in patients with NHL reveals involved 
mesenteric nodes in up to 51% of cases, more commonly in 
association with involved retroperitoneal nodes than with 
normal retroperitoneal findings (4,6,11,17). 
Mesenteric lymph-node enlargement was detected with CT in 
9 out of our 91 patients (10%), but exclusively in 
conjunction with abnormal retroperitoneal nodes on CT or 
lymphography. Involved mesenteric and celiac nodes may be 
present when the lymphogram is negative, but are then 
usually not markedly enlarged, making discovery by CT more 
difficult (11). The actual incidence of mesenteric lymph-
node involvement in our patients could not be determined 
because staging laparotomy was not routinely performed. 
The relatively low yield of CT in our series suggests that 
involved mesenteric nodes in our patients were probably 
overlooked, and supports the contention that CT 
contributes little in correcting the deficiencies of other 
non-invasive staging methods in this regard. 
Abdominal CT can detect subtle enlargement of the so-
called retrocrural lymph nodes, which are in fact nodes in 
the postero-inferior portion of the mediastinum (8). 
Ellert (9) diagnosed retrocrural lymph-node enlargement in 
23% of patients. In the present series, CT visualized 
enlarged retrocrural nodes in 57% of patients with 
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combined retroperitoneal and upper mediastinal node 
involvement. In patients with abdominal node involvement 
and normal chest findings, CT detected retrocrural node 
enlargement in 11%, and thus proved supradiaphragmatic 
spread of disease. Enlarged retrocrural nodes were not 
detected in patients with normal abdominal CT or 
lymphography findings. 
Staging laparotomy reveals splenic involvement with 
lymphoma in 30% to 50% of cases (4,17). In previous 
studies we analysed the efficacy of splenic index 
calculation with CT in patients with HD (24) and with NHL 
(23). 
An accuracy rate of over 90% with an equally high 
sensitivity and specificity rate in diagnosing splenic 
involvement with lymphoma could be obtained in these 
stuaies. In the present study, the splenic index was 
calculated retrospectively in Θ4 out of 91 patients (table 
4). 
The spleen was enlarged (i.e. an index over 480) in 30 
patients (36%) and of normal size in the remaining 54 
patients (64%). In 10 cases the spleen was available for 
histologic examination, and the diagnostic accuracy of 
splenic index calculation was 100%. 
According to Castellino et al. (6) 89% of patients with a 
normal lymphogram proved to have a histologically normal 
spleen, whereas in 52% of patients with a positive 
lymphogram the spleen was involved. 
In the present study, the spleen was of normal size by 
splenic index calculation in 80% of patients with a normal 
lymphogram, whereas the spleen was enlarged in 49% of 
patients with a positive lymphogram. These results are not 
markedly different from the results of Castellino et al., 
and suggest that splenic index calculation as a parameter 
for splenic involvement with lymphoma might be helpful. 
For a definitive answer, a larger, prospective study is 
necessary. 
Liver involvement is difficult to diagnose with CT, 
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resulting in a very low sensitivity (26). Fifty-seven 
patients in the present study were subjected to a blind 
percutaneous liver biopsy, and lymphoma was demonstrated 
in 11 cases (19%). CT of the-liver was normal in all cases 
except 1 with positive histologic findings. False-positive 
CT-scans were not encountered. 
Organ involvement (other than liver and spleen) is not 
uncommon in patients with NHL (9,10,17,19). Seven out of 
91 patients in the present series had gastro-intestinal 
localization of lymphoma, but in all patients this was 
known or suspected by physical examination. Barium 
examination or endoscopy prior to staging. Furthermore, it 
was the first clinical manifestation of disease in 5 
patients. Except for 2 patients all had concomitant 
retroperitoneal lymph-node involvement. 
In one patient bone abnormalities adjacent to a region of 
massive lymph-node enlargement were noticed with 
lymphography. One patient each showed involvement of both 
kidneys, homolateral kidney and adrenal, and the female 
genital system. Abdominal organ involvement in the absence 
of lymph-node involvement was not detected with CT in our 
series, although this may occur (10). 
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ABSTRACT 
CT of the spleen was correlated with histologic 
examination or clinical data in 53 selected patients with 
non-Hodgkin's lymphoma. 
Calculation of the splenic index with CT by multiplying 
spleen length, width and thickness is a simple and quick 
procedure to define splenic size in vivo. 
A good correlation was found between size of the spleen, 
as estimated by splenic index calculation, and the proven 
or probable histologic state of the spleen. 
INTRODUCTION 
The size of the spleen in patients with Hodgkin's disease 
(HD) or non-Hodgkin's lymphoma (NHL) is generally regarded 
as an unreliable indicator of splenic involvement. 
Apparently normal-sized spleens often reveal localization 
of lymphoma, whereas spleens thought to be involved on the 
basis of non-invasive examination methods are not 
uncommonly histologically normal. Computed tomography (CT) 
has made it possible to outline the size of the spleen 
more exactly, but most published series showed a poor 
correlation between CT of the spleen and histology. 
Overall accuracy rates varying from 60 to 100%, with a 
sensitivity ranging from 0 to 100% and a specificity 
ranging from 80 to 100% have been reported (1,2,4,6,7,15, 
16,18,19). These results may be explained partially by the 
use of different and obviously insensitive criteria. 
In a previous report (16) we analysed the value of the 
"splenic index" as an in vivo indicator of splenic size 
and involvement in patients with HD. An overall accuracy 
of 91% with a sensitivity of 89% and a specificity of 94% 
could be obtained in evaluation of splenic involvement in 
a series of 35 patients. 
The objective of the present study is to evaluate the 
results of splenic index calculation in patients with NHL. 
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MATERIAL AND METHODS 
CT findings of the spleen were evaluated retrospectively 
in 53 patients with NHL, examined during the years 1978 to 
1985. These patients were selected from the population of 
patients with NHL attending the Department of Hematology 
of our Hospital, after either direct or indirect evidence 
of the histologic state of the spleen had been available 
(group A and group В respectively). Because staging 
laparotomy was not performed routinely, we gathered data 
from various sources. 
Group A consisted of 33 patients of whom histology of the 
spleen was obtained by means of autopsy (23 patients) or 
laparotomy (10 patients). Staging laparotomy was performed 
in 3 patients, and laparotomy with splenectomy for other 
than staging purposes in the remaining 7 patients. 
Group В consisted of 20 patients of whom splenic tissue 
for a direct histologic diagnosis was not available. The 
probable presence or absence of disease in the spleen in 
these cases was deduced from data on clinical and 
pathological stage, such as histologically proven liver 
involvement (11 patients) or from follow-up during at 
least 4 years with patients with limited disease who were 
treated locally (9 patients). A positive liver biopsy was 
considered to be an indirect sign of splenic involvement. 
A recurrence-free survival after local (involved-field) 
radiotherapy was regarded as a confirmation of initially 
negative CT findings. These patients are referred to in 
figure 2 as "indirect histology" cases. 
CT was performed in 45 patients on an Ohio Nuclear 50 FS 
Delta Scanner with a scanning time of 18 seconds. 
Contiguous scanning with a slice thickness of 13.5 mm of 
the upper abdomen was performed during suspended 
expiration. 
Intravenous contrast material was not administered 
routinely. Seven patients were examined on a Siemens 
Somatom DR 3 with a scanning time of 5 seconds and a slice 
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thickness of 8 mm at 16 mm intervals. One patient was 
referred with a CT scan made elsewhere. 
The splenic index according to Lackner et coll. (13) was 
calculated by multiplying spleen length, width and 
thickness as measured with CT. Spleen length is considered 
to be equivalent to the sum of all slice thicknesses (and 
intervals if used) on which the spleen is to be seen. 
Spleen width and thickness are the (straight) antero­
posterior and transverse organ diameter respectively, 
usually at the level of the splenic hilum (fig. 1). 
Lackner found an index of 480 as upper limit in a series 
of 100 normal spleens. We adopted this value to define 
normal spleen size on CT. By definition, an index higher 
than 480 indicated splenic enlargement, and this was 
regarded as a radiological sign of splenic involvement. 
b. 
Fig. 1: Measurement of spleen dimensions in various spleen shapes 
(tracings from СГ sections). 
a. Width = longest transverse diameter, regardless of scan 
height through spleen or spleen orientation. 
b. Thickness = distance fron inner to outer surface, 
directly measured or mean value in cases with marked 
spleen asymmetry. 
(Reprinted fron S.P. Strijk et coll.: The spleen in Hodgkin disease: 
diagnostic value of CT. Radiology 154 (1985), 753. With permission.) 
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RESULTS 
Group A, patients of whom spleen histology was available. 
This group consisted of 33 patients, of whom 10 were 
female and 23 were male. The ages ranged from 20 to 81 
years, with a mean age of 57 years. 
Three patients underwent primary diagnostic and staging 
laparotomy with splenectomy because of infradiaphragmatic 
disease presentation. None of them had liver or spleen 
involvement. The splenic index ranged from 342 to 454 
(mean value 449), and splenic weight ranged from 156 g to 
320 g (mean value 255 g). 
Seven patients underwent laparotomy for therapeutic 
splenectomy. The spleen was histologically involved in all 
cases. The splenic index ranged from 621 to 3278 (mean 
value 1923). In 4 patients splenectomy was performed after 
completion of clinical staging, prior to therapy. The 
3 other patients had received therapy, or showed clinical 
progression of disease between the moment of CT and 
splenectomy, and this made comparison of splenic index and 
weight less valid. Hepatic involvement with lymphoma was 
demonstrated in 2 of 4 patients with liver histology 
available. 
In 23 patients radiologic findings were correlated with 
autopsy data. Three patients had a splenic index lower 
than 480, and the spleen proved to be histologically 
uninvolved. The remaining 20 patients had splenic 
involvement at the time of death. The splenic index in 
the latter group ranged from 509 to 3888 (mean value 
1240). Splenic weight at autopsy ranged from 290 g to 1910 
g. The interval between radiologic examination and autopsy 
varied from 10 to 210 days (average: 85 days). 
Moreover, most patients in the autopsy-group were 
characterized by generalized disease. Causes of death were 
mainly intractable progress of disease, complicating 
diseases or a combination of both. Hepatic involvement by 
lymphoma was demonstrated in 16 out of 18 patients of whom 
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liver histology was available. 
In the total group of 33 patients, splenic index 
calculation showed an accuracy rate of 100% in predicting 
the histologic state of the spleen (table la). 
Table la: Group A, 33 patients of whom spleen histology was 
available. 
Hist. 
CT 
+ 
•Dotal 
-
6 
0 
6 
+ 
0 
27 
27 
to ta l 
6 
27 
33 
Group B, patients of whom spleen histology was not 
available. 
Eleven patients had hepatic involvement demonstrated by 
percutaneous liver biopsy. Six patients were female, 5 
were male. Ages ranged from 30 to 67 years (mean age 42 
years). The biopsy was taken between 13 days before and 9 
days after CT. The splenic index ranged from 416 to 1985 
(mean value 804). Two patients had an index below the 
threshold value of 480. One of these patients had just 
finished 6 courses of chemotherapy. The remaining 9 
patients had an index above 480. 
A control group consisted of 9 patients with NHL and 
localized disease (stage IA or IE clinically). Five were 
female, 4 were male. Ages ranged from 43 to 82 years (mean 
age 62 years). They all received local radiotherapy and 
were followed 4 to 7 years without signs of recurrence or 
progression of disease. The splenic index in this group 
ranged from 146 to 399 (mean value 285). 
Due to the lack of definitive histologic data on the 
spleen in this group of patients, only extrapolated 
accuracy, sensitivity and specificity rates were 
calculated. They amounted to 90%, 82% and 100% 
respectively (table lb). 
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Table 1b: Group В, 20 patients of whom spleen histology was not 
avai leíble. 
Hist.* 
CT 
-
+ 
Total 
-
9 
0 
9 
+ 
** 
2 
9 
11 
total 
11 
9 
20 
* no direct histologic proof available (see text) . 
** one patient examined after treatment. 
Table 2 compares t he h i s t o l o g y of l i v e r and spleen in 26 
p a t i e n t s with m a t e r i a l a v a i l a b l e . All 17 p a t i e n t s with 
h i s t o l o g i c a l l y proven hepa t i c involvement had s p l e n i c 
involvement as w e l l . 
Table 2 : Comparison of spleen and liver histology. 
Localization of lymphoma present (+) or 
absent ( - ) . 
liver 
spleen 
+ 
Total 
-
5 
4 
9 
+ 
0 
17 
17 
total 
5 
21 
26 
Figure 2 p r e s e n t s a diagram comparing s p l e n i c index and 
s p l e n i c weight . In a previous s tudy on p a t i e n t s with HD 
(16) , the mean weight proved t o be equ iva l en t t o 0.55 χ 
s p l e n i c index. This conversion f a c t o r i s t r a n s f e r r e d t o 
f igure 2, which shows the r e s u l t s of t h e p r e s e n t s t u d y . 
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splenic weight (g) 
1500-
1000 
500-
ο · splenectomy cases 
cmaulopsy cases 
ΛΑ indir histol cases 
wetght 4 * Δ ^ 4 Λ MfM 
unknown 
500 1000 1500 2000 2500 
splenic index 
Fig. 2: Correlation between splenic weight and splenic index of 
involved ( ·•* ) or oninvolved ( Ο Π Δ ) spleens (see text) . 
Splenic index of 480 as upper limit of normal range. 
(* The actual »eight and index of these spleens were both 
divided by factor 2 in order to simplify inclusion in the 
diagram). 
INDIR. HISTOL. CASES: i n d i r e c t evidence of spleen 
histology only (see text). 
DISCUSSION 
With patients suffering from malignant lymphoma (HD and 
NHL), subjected to staging laparotomy, the spleen is found 
to be histologically involved in 23% to 50% of cases (3, 
5,6,9,10,12,14,17). Although there is an increasing 
incidence of splenic involvement with increasing weight of 
the specimen, there is no absolute correlation between 
weight as measured after splenectomy and histologic 
state. Only spleens weighing more than 500 g were 
consistently involved with lymphoma, whereas lymphoma was 
not infrequently absent in smaller spleens (8,10,17). 
Determination of the weight of the spleen after operative 
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removal is liable to inaccuracies, because it is 
influenced by the operative technique and the variable 
amount of blood contained in or lost from the specimen. We 
evaluated the correlation of splenic index calculation by 
CT with regard to splenic involvement. In this way an in 
vivo measurement of splenic volume is made. In a previous 
report we discussed the value of CT in examination of the 
spleen in patients with HD (16). Calculation of the 
splenic index - a parameter for splenic volume and weight 
in vivo - appeared to be of value in determining the 
presence or absence of disease in the spleen in these 
patients with a sensitivity of 89%, a specificity of 94%, 
and an overall accuracy of 91%. Herter et coll. (11) 
applied a similar measurement in 34 patients with 
malignant lymphoma (27 HD, 7 NHL) and established a 
diagnostic accuracy of 83% with a specificity of 86% and a 
sensitivity of 77%. 
In the present study we assessed whether splenic size 
determination with CT could be of value in the examination 
of patients with NHL. In HD, the presence and extent of 
intra-abdominal disease are important factors, directly 
influencing the choice of therapy in many cases.In NHL, 
not only the stage of disease, but also the histologic 
classification is important, because both factors 
influence the prognosis to a varying extent. Staging 
laparotomy has now largely been abandoned as a routine 
procedure in most patients with NHL. Routine clinical 
staging including bone-marrow biopsy, liver biopsy, 
lymphangiography and/or CT is usually found to give 
sufficient information. 
The composition of the present patient group is basically 
different from our previous study, because data were not 
mainly obtained from patients subjected to staging 
laparotomy. The present evaluation of splenic index 
calculation in patients with NHL has therefore the nature 
of a feasibility study, due to the unhomogeneous and 
selected composition of the patient group. The final 
conclusions should be considered against this background. 
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The main indication for staging laparotomy in our Hospital 
is a clinical stage IA or IIA in patients with NHL of 
intermediate or high-grade malignancy. 
Because this condition occurs in only a minority of 
patients, a relatively small number of histologically 
verified normal spleens in patients with NHL· are included 
in the present series. The splenic index in these 3 
laparotomy patients was within normal limits. Likewise, in 
3 patients having a histologically normal spleen at 
autopsy, the splenic index was not increased. We also 
found a normal splenic index (ranging from 146 to 399) in 
a group of 9 patients with NHL and limited disease extent 
who had received local radiotherapy only, resulting in 
complete remission. In these 9 cases the spleen was not 
histologically examined but the clinical course made the 
assumption very likely, that the spleen was not involved 
as none of the patients showed signs of recurrence of 
disease during a follow-up period of 4 to 7 years. 
Indications for therapeutic splenectomy are signs of 
hypersplenism (anemia, leukopenia, thrombocytopenia), 
local discomfort due to massive enlargement and 
infarctions, or the need for reduction of tumor volume. In 
these patients the spleen will usually be markedly 
enlarged, and virtually always involved with lymphoma. 
Seven patients were included in this group. The splenic 
index ranged from 621 to 327Θ (mean value 1923). The 
spleen proved to be involved with lymphoma in all cases. 
Finally, patients dying from lymphoma usually have poorly 
responsive or recurrent disease associated with a large 
tumor volume and sometimes complicating diseases. The 
splenic index in the 20 patients with an involved spleen 
at autopsy ranged from 509 to 3888, with a weight of the 
autopsy specimen of 290 g to 1910 g. In 3 other patients, 
the splenic index was not increased and at autopsy the 
organ was found to be not involved. 
Literature data indicate that the presence of lymphoma in 
the liver practically always implies that the spleen is 
involved as well (9,17). We confirmed this finding: all 
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patients with proven hepatic involvement, of whom splenic 
tissue was available, also showed splenic involvement 
(table 2). 
Consequently, a positive liver biopsy can be regarded as 
reflecting splenic involvement. In this study we have 
included 11 patients with a positive liver biopsy of whom 
spleen histology was not available. Two patients had an 
index within the normal range i.e. lower than 480. In 1 of 
them, the liver biopsy was taken after completion of 6 
courses of chemotherapy. Pretreatment CT was not 
available, and it might be speculated that this 
false-negative reading was in fact due to a decrease in 
splenic volume after therapy.The other (untreated) patient 
with biopsy-proven hepatic involvement and a normal-sized 
spleen on CT has to be regarded by our criteria as a 
false-negative CT-reading. 
Summarizing the data presented above, we may conclude that 
the calculation of the splenic index with CT in the group 
of 33 patients of whom spleen histology was available 
resulted in a diagnostic accuracy of 100% in 
discriminating normal from involved spleens. It should be 
stressed again that patient selection was not at random, 
but biased in favour of patients having splenomegaly and 
advanced disease. 
In the second group of 20 patients with only indirect 
proof of spleen histology, the extrapolated figures for 
accuracy, sensitivity and specificity are 90%, 82% and 
100% respectively. 
Similar results will probably not be attainable with 
patients with NHL presenting for initial staging. A 
prospective study on this subject with use of splenic 
index calculation or employing CT-facilities for more 
exact volume calculations, and an evaluation in a group of 
patients undergoing staging laparotomy would provide a 
conclusive answer on the validity of our results. 
According to our previous study in patients with HD, the 
average spleen weight is approximately equal to 0.55 χ 
splenic index (16). Thus, an index of 480 as upper limit 
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for normal size (13) corresponds to a weight of 265 g. 
Several other studies revealed that a splenic weight of 
more than 500 g consistently implicated splenic involvement 
(8,10,17). It was calculated that weight determination when 
using a weight of 500 g as threshold value would for the 
present series result in an accuracy of 77%, a specificity 
of 100% and a sensitivity of 72%. 
A weight of 500 g would be equivalent to an index of 910. 
Application of this modified index threshold to the same 
group of patients in our series would result in a 
diagnostic accuracy of 73%, a specificity of 100% and a 
sensitivity of 67%. 
Both results are not substantially different and support 
the value of splenic index calculation as an easy in vivo 
measurement, at least as reliable as weight determination. 
The splenic index calculation offers an alternative to 
define splenic size in vivo, and obviates the crude 
criteria used by most authors. It can also be used to 
document splenic size in follow-up studies. 
In the clinical staging of patients with malignant lymphoma 
it may be of value to derive more information from the 
abdominal CT that has already been performed in most 
patients. It is our experience (16) that a threshold value 
of 480 is highly reliable in separating normal-sized from 
enlarged spleens, or histologically normally from 
histologically involved spleens. 
The threshold value can be chosen arbitrarily, in which 
case a higher value decreases the sensitivity but also 
decreases the number of false-positive diagnoses. 
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ABSTRACT 
Radiologic examinations of the chest in 331 patients with 
malignant lymphoma (204 patients with non-Hodgkin lymphoma 
(NHL), 127 patients with Hodgkin disease (HD)) were 
evaluated retrospectively. Tomography of the mediastinum 
was performed in 52 cases. No additional information was 
obtained in patients with a clearly normal or abnormal 
chest radiograph. Only with patients with equivocal chest 
radiographs tomography was helpful. 
Computed tomography (CT) of the chest was performed in 76 
cases (49 NHL, 27 HD). This revealed abnormalities in 7% 
of patients with a normal chest radiograph (14% in HD, 4% 
in NHL). CT revealed additional lesions in 23% of patients 
with an abnormal chest radiograph (20% in HD, 25% in NHL). 
Overall, CT changed the clinical stage of disease in only 
2 out of 76 cases (3%). Both patients had HD, and thus CT 
was responsible for a change of the clinical stage in 2 
out of 27 patients with HD (7%), and in none of the 
patients with NHL. 
INTRODUCTION 
Hodgkin disease (HD) and non-Hodgkin lymphoma (NHL) 
frequently show intrathoracic spread at the time of 
initial diagnosis, and chest radiography is therefore one 
of the most rewarding examinations in the staging of these 
patients. 
Conventional tomography and computed tomography (CT) are 
more time-and-money-consuming examinations, but may 
provide additional information in a number of cases. 
However, the final impact on initial diagnosis and staging 
seems to be very limited (1). 
In the present study we discuss the radiologic 
examinations of the chest (conventional radiography, 
mediastinal tomography, computed tomography) in a group of 
331 patients staged for primary or recurrent malignant 
lymphoma. 
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MATERIAL AND METHODS 
During the years 1978 to 1985, radiologic examination of 
the chest was performed in- 331 patients with malignant 
lymphoma undergoing staging for either newly diagnosed and 
untreated, or recurrent disease. 
All patients had frontal and lateral chest radiographs. 
Fifty-two patients also underwent frontal tomography of 
the mediastinum, incidentally supplemented by lateral 
tomography of the hila and/or retrosternal space. 
Seventy-six patients underwent CT of the chest. Of these, 
15 patients were examined with the use of an Ohio Nuclear 
50 FS Delta Scan, with a scanning time of 18 seconds, and 
a slice thickness of 13.5 mm. Contiguous scanning of the 
whole chest was performed during suspended inspiration. 
Fifty-eight patients were examined with the use of a 
Siemens Somatom DR 3 with a scanning time of 5 seconds, 
and a slice thickness of 8 mm at β or 16 mm intervals. 
Three patients were referred with a CT scan made 
elsewhere. Intravenous contrast medium was not routinely 
administered. 
Practically all patients with equivocal findings at chest 
radiography underwent mediastinal tomography or computed 
tomography. However, most patients had definitely normal 
or abnormal chest radiographs, and during the years of the 
study, there were no strict indications for carrying out 
additional examinations in these patients. The relative 
distribution of supplementary examination in the various 
patient groups divided by type of disease and findings at 
chest radiography is given in table 1. 
The specific examinations were evaluated for the presence 
of enlarged lymph nodes (suggesting involvement with 
lymphoma) and for the presence of extranodal localization 
of lymphoma. The lymph-node regions (mediastinal, hilar, 
retro- and parasternal) were not evaluated separately, but 
any local, regional or generalized involvement was coded 
as "positive" for chest involvement. 
Extranodal manifestations of disease (pulmonary 
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parenchyma, p l e u r a , c h e s t w a l l , bone) were recorded 
s e p a r a t e l y . 
The i n i t i a l r e p o r t s of t h e v a r i o u s e x a m i n a t i o n s were 
m a i n t a i n e d . R e v i s i o n of t h e r a d i o l o g i c e x a m i n a t i o n s was 
undertaken i n c a s e s w i th d i v e r g e n t r e s u l t s in order t o 
determine t h e c a u s e of t h e d i s c r e p a n c y . 
Table 1: Relative frequency of radiologic examinations in 331 
patients with malignant lymphoma (NHL : η = 204 and 
HD : η = 127). 
% supplementary examination 
chest 
radiograph 
tomography СГ 
normal 
abnormal 
equivocal 
NHL 
HD 
total 
NHL 
HD 
total 
NHL 
HD 
total 
143 
66 
209 
50 
53 
103 
11 
8 
19 
6 
12 
8 
18 
32 
25 
55 
38 
47 
20 
21 
20 
32 
19 
25 
45 
38 
42 
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RESULTS 
Radiologic examination of the chest was performed in 331 
patients with malignant lymphoma. Two hundred and four 
patients had NHL and 127 patients had HD. A survey of the 
radiologic examinations is given in table 1. 
Of the 204 chest radiographs in patients with NHL, 143 (= 
70%) were normal, 50 (= 25%) were abnormal, and 11 (= 5%) 
were equivocal. 
Of the 127 chest radiographs in patients with HD, 
66 (= 52%) were normal, 53 (= 42%) were abnormal, and θ 
(= 6%) were equivocal. 
In patients with NHL having normal chest radiographs 
(n = 143), an additional examination was performed by 
tomography in 9 (= 6%) and CT in 28 (= 20%). In patients 
with HD having normal chest radiographs (n = 66), 
additional examination was performed by tomography in 8 (= 
12%) and CT in 14 (= 21%). 
In the NHL-patients having an abnormal chest radiograph 
(n = 50), additional examination was performed by 
tomography in 9 (= 18%) and CT in 16 (= 32%)of them. In 
the HD-patients with an abnormal chest radiograph (n = 
53), additional examination was performed by tomography in 
17 (= 32%) and CT in 10 (= 19%). 
Overall 36% of patients with NHL and 43% of patients with 
HD underwent additional examination. 
Of the 127 patients with HD, 96 (= 76%) had newly 
diagnosed and untreated disease, and 31 (= 24%) were 
staged for recurrent disease. The number of CT scans 
carried out was distributed proportionally between the 
groups. Of the 204 patients with NHL, 173 (= 85%) had 
newly diagnosed and untreated disease, and 31 (=» 15%) were 
staged for recurrent disease. In these patients the CT 
scans were distributed proportionally too. 
Because discrepant findings in chest radiology of patients 
with HD and NHL having either primary or recurrent disease 
were relatively few, the results of the various 
examinations are evaluated together. 
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Chest rad iograph v e r s u s CT 
Table 2: Comparison of chest radiograph (Xth) and CT in 76 
patients (NHL : η = 49 and Ш : η = 27). Lymphona 
local izat ion radiologically present (+), absent(-) 
or equivocal ( ± ) . 
СГ - + t o t a l 
Xth 
NHL 
HD 
total 
NHL 
HD 
total 
NHL 
HD 
total 
NHL 
HD 
total 
27 
12 
39 
3 
2 
5 
30 
14 
44 
1 
2 
3 
16 
10 
26 
2 
1 
3 
19 
13 
32 
28 
14 
42 
16 
10 
26 
5 
3 
8 
49 
27 
76 
The discrepancies between the chest radiographs and CT 
scans are summarized in table 3. 
CT revealed enlarged intrathoracic lymph nodes in 3 out of 
42 patients with a normal chest radiograph (= 7%). This 
occurred in 1 out of 28 patients with NHL (= 4%) and in 2 
out of 14 patients with HD (= 14%) (fig. 1). All CT scans 
were abnormal with regard to the lymph nodes in patients 
with an abnormal chest radiograph. However, in 3 of the 
patients (1 out of 10 with HD (= 10%), and 2 out of 16 
with NHL (= 13%)) CT also detected intrapulmonary lesions 
not visible on the chest radiograph (fig. 2). In 2 other 
patients (with NHL and HD) with pleural and pulmonary 
localization respectively which were visible on the chest 
radiograph, CT detected additional mediastinal 
lymphadenopathy (fig. 3). 
In 8 patients with an equivocal chest radiograph, CT was 
normal in 5 and abnormal in 3 cases. 
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Fig.1: Case 3. Female patient of 63 years with HD. Chest radiograph 
normal. CT reveals enlarged left internal manmary nodes, and 
enlarged nodes in the aortic-pulmonary window. 
Also minimal amount of pleural fluid. 
a b 
Fig. 2 : Case 4. Female patient of 15 years with HD. 
2a: Enlarged mediastinal and hilar lymph nodes. 
2b: CT demonstrates intrapulmonary lesion (arrow) anterior to 
the right hilan, not visible on AP and lateral chest 
radiograph. 
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Table 3: Specification of discrepancies between chest radiograph and 
CT. Τ realization of lymphana radiologicctlly present (+) or 
absent (-). 
Pat. 
nr. 
1 
2 
3 
4 
5 
6 
7 
Hist. 
NHL 
HD 
HD 
HD 
HD 
NHL 
NHL 
ehest 
nodes 
-
-~ 
~ 
+ 
-
+ 
— 
radiogr. 
lextra-
1
 nodal 
-
— 
™ 
-
+ 
(pleura) 
+ 
(pleura) 
+ 
(lung) 
CT 
nodes extra­
nodal 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
— 
-~ 
+ 
+ 
++ 
+ 
change 
of clin. 
stage 
-
— 
+ 
+ 
-
-
-
notes 
chest wall lesion 
externally visi­
ble; fig. 4 
primary infradia-
phra^natic pre­
sentation; fig. 1 
fig. 2 
additional pleural 
lesions 
pulmonary paren­
chyma recurrence; 
fig.3 
NHL 
NHL 
(lung) 
additional pulmo­
nary nodules; 
abdoninal organ 
localization 
also gastro-intes­
tinal localization 
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C h e s t r a d i o g r a p h v e r s u s t o m o g r a p h y 
Table 4; Comparison of chest radiograph (Xth) and tomography 
(torn.) in 52 p a t i e n t s (NEIL : η = 24 and Ш : n = 2 8 ) . 
Lymphoma l o c a l i z a t i o n radio log ica l ly present ( + ) , a b s e n t 
(-) or equivocal ( ± ) . 
torn. - + ± t o t a l 
Xth 
NHL 
HD 
total 
NHL 
HD 
total 
NHL 
HD 
total 
9 
8 
17 
3 
1 
4 
a 
17 
25 
3 
2 
5 
9 
8 
17 
9 
17 
26 
6 
3 
9 
total 
total 
grand 
NHL 
HD 
total 
12 
9 
21 
11 
19 
30 
1 
1 
24 
28 
52 
Conventional antero-posterior tomography of the 
mediastinum confirmed definitely normal and abnormal 
chest radiographs in all but one case. 
In 9 patients with equivocal findings, tomography was 
normal in 4, and abnormal in 5 cases. No additional extra-
nodal localizations were diagnosed. 
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DISCUSSION 
Intrathoracic spread of lymphoma is a frequent occurrence 
in patients with HD or NHL. The incidence in patients with 
newly diagnosed HD is reported to be as high as 67%, 
whereas the incidence in patients with NHL is generally 
lower - up to 43% (2-5). A comparable difference is 
evident in the present series: 42% and 25% respectively. 
Intrathoracic manifestations of lymphoma usually consist 
of enlarged lymph-node masses in the mediastinal, hilar, 
retrosternal (thymic) and parasternal (internal mammary) 
regions. Involvement of lung parenchyma is much more 
uncommon: 11.6% in HD and 3.7% in NHL according to Filly 
et al. (3). Usually, there is accompanying mediastinal or 
hilar lymph-node involvement in these cases, at least in 
newly diagnosed patients with HD. In patients with NHL, 
and in patients with recurrent disease, isolated 
pulmonary lesions occur more frequently (3,6). 
Conventional tomography: 
Standard frontal and lateral chest radiography is a highly 
informative examination in patients with malignant 
lymphoma. Multiple lymph-node regions can be evaluated at 
one glance. Full-lung tomography can give a significant 
amount of additional information, but Castellino et al. 
(1) found that the clinical stage of disease changed in 
only 1.2% of patients. North et al. (7) found an equally 
low yield. 
The superiority of full-lung tomography over conventional 
chest radiography in detecting intrathoracic abnormalities 
when staging is concerned is not the fact that tomography 
visualizes more involved lymph-node regions. 
A change of stage is effectuated by detecting enlarged 
nodes in a patient with a normal chest radiograph, by 
visualizing extranodal spread of disease, or visualizing 
parenchymal, pleural or chest wall localizations. The 
latter findings upstage the patient to stage IV disease, 
and influence the choice of therapy directly in many 
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cases. In our retrospective study frontal mediastinal 
tomography proved to be ineffective, probably because only 
parts of the lungs were visualized. None of the 
examinations yielded additional information, whereas 
Castellino et al. found unexpected abnormalities with 
full-lung tomography in 21.4% of patients (1). It is our 
experience that mediastinal tomography proved to be useful 
in patients with equivocal chest radiographs only, and it 
was not rewarding when the chest radiograph was either 
clearly normal or abnormal. 
Computed tomography; 
The superiority of CT compared with chest radiography and 
tomography suggests that this technique will have a higher 
yield (8-12). Comparable data, as produced by Castellino 
on lung tomography (1) are still not available in medical 
literature. Rostock (12,13) diagnosed unexpected intra­
thoracic disease in 5 out of 10 patients suffering from HD 
having a normal chest radiograph. Shiels et al. (14) found 
evidence of lymphoma in 2 out of 24 patients (= 8%) having 
HD and a normal chest radiograph. Cohen et al. (15) found 
that chest CT changed the stage of disease in б out of 22 
children (27%) investigated for malignant lymphoma. Khoury 
et al. (16) detected pathologic findings in 5 of 18 
patients with NHL having a normal chest radiograph (= 
28%) . 
CT was indeed more productive than conventional radiology 
in our patients. 
In 3 out of 42 patients with a normal chest radiograph 
(= 7%), CT revealed intrathoracic lymph-node involvement 
(cases 1-3) (fig. 1). The 3 patients had newly diagnosed, 
untreated disease. In 1 of these patients, HD was found in 
a biopsy of a retro- and parasternal mass that protruded 
on the outside of the chest wall, and that was palpable at 
physical examination (fig. 4). CT therefore did not modify 
the clinical stage for this patient. In the 2 remaining 
patients, the clinical stage was changed in only 1 case. 
A normal chest radiograph in combination with lymph-node 
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enlargement discovered by CT occurred in 4% of patients 
with NHL·, and in 14% of patients with HD. This is 
compatible with the fact that chest involvement occurs 
more frequently in HD (as already demonstrated) and that 
lymph nodes involved with HD tend to be smaller than in 
NHL, and easier escape detection with conventional 
techniques. 
Although our group is small, it conforms to the conclusion 
of Castellino et al., that supplementary investigation of 
the chest in NHL is the least rewarding. In their 
experience, it gives significant additional findings in 
only 1.1% of patients (1). These authors found in HD in 
6.7% of cases significant information leading to change of 
stage and/or therapy. 
Two other patients in the present series had only 
pulmonary and pleural lesions respectively shown by the 
chest radiographs. CT subsequently visualized enlarged 
mediastinal nodes (fig. 3). However, these findings did 
not change the stage of disease in these patients. 
We did not compare the potential difference in the number 
of involved lymph-node regions diagnosed with either CT or 
chest radiography. It has been proven that treatment plans 
are influenced significantly by this aspect of superiority 
of CT (12,17,18), but clinical staging will not be 
markedly affected. 
The greatest profit of performing full-lung tomography, 
-and a fortiori CT-, lies in the detection of occult 
mediastinal disease and unexpected pulmonary 
abnormalities. The latter finding will usually upstage the 
patient to stage IV disease and modify the treatment plan 
accordingly. Castellino et al. (1) found with full lung 
tomography such lesions in 4.5% of patients. Shiels found 
in 2 out of 11 patients with HD and an abnormal chest 
radiograph additional abnormalities with CT (14). 
In the present study, CT detected additional lesions in б 
out of 26 patients with unequivocally abnormal chest 
radiographs (cases 4-9). Three out of these were 
intrapulmonary lesions, not visible on the chest 
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radiographs (fig. 2), 1 was a pleural lesion, and in 2 
cases mediastinal lymph nodes were seen in patients with 
lung lesions. Two out of these 6 patients had HD, and thus 
additional findings were made in 20% of patients with HD 
and an abnormal chest radiograph. 
The remaining 4 patients had NHL, and thus CT was 
responsible for additional findings in 25% of NHL-patients 
with an abnormal chest radiograph. 
In 4 of the б patients, these additional lesions implied a 
clinical stage IV, but 3 patients were already known to 
have stage IV on the basis of other clinical data. The 2 
remaining patients already had stage IV disease by 
radiology, and the additional CT-findings were thus not 
influential. As in most series, histological examination 
of the pulmonary lesions was not performed. 
Summarizing the results, we can draw the following 
conclusions from the present material: 
1 . CT revealed abnormalities in 7% of lymphoma patients 
with a normal chest radiograph (14% in HD, 4% in NHL). 
2. CT revealed additional lesions in 23% of lymphoma 
patients with an abnormal chest radiograph (20% in HD, 
25% in NHL). 
3. CT changed the clinical stage of disease in only 2 out 
of 76 patients with malignant lymphoma (3%). Both 
patients had HD, and thus CT was responsible for a 
change in the clinical stage in 2 of 27 patients with 
HD (=7%), and in none of the patients with NHL. 
Thus, the net result of using CT as an additional 
examination in the staging procedure was of only minor 
importance, again confirming the conclusions of Castellino 
et al. (1) relating to the performance of full-lung 
tomography. 
Routine CT of the chest seems not to be justified in each 
patient, presenting with malignant lymphoma. It should 
only be performed when potential additional information 
might influence therapy strategies. 
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Fig. 3: Case 7. Female patient of 57 years with (histologically 
proven) recurrence of NHL in the right lung. 
Qilarged retrosternal nodes (fig. 3b) not seen on chest 
radiograph (fig. 3a). Also enlarged left axillary nodes. 
Fig. 4: Case 2. Male patient of 33 years with HD. 
Retro- and parasternal lesion on the right side, 
infiltrating the pectoral muscle. Lesion was not visible on 
chest radiograph, but was palpable. 
Biopsy of this lesion revealed H). 
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ABSTRACT 
Lymph node calcification in malignant lymphoma is an 
uncommon radiologic finding. Eight cases are added to the 
61 cases of lymph node calcification following radiation 
therapy for Hodgkin's disease, assembled from the 
literature. The typical radiographic appearance of 
punctate calcifications, usually found in the upper 
mediastinum, at times together with egg-shell type 
calcification, is confirmed. The mean time before 
appearance of calcification was 3 years after initial 
treatment. The calcification seems to be associated with a 
good prognosis and longterm survival. In addition, the 
radiologic and clinical findings in a patient with non-
Hodgkin's lymphoma who developed calcifications in the 
involved area after treatment are presented. 
INTRODUCTION 
Calcification of lymph nodes in patients with malignant 
lymphoma is an uncommon finding. Most reports concern 
patients with Hodgkin's disease (HD) undergoing radiation 
therapy (3,4,6,7,9-17,19-26,28). Few reports describe the 
appearance of calcification after chemotherapy alone (1,2, 
6). Lymph node calcification (LNC) following therapy for 
non-Hodgkin's lymphoma (NHL) is only infrequently 
mentioned in the literature (2,6). Even more unusual is 
the occurrence of LNC in patients with untreated malignant 
lymphoma; only three reports could be traced in the 
literature (5,8,27). 
The present account gives a short review of the literature 
on this subject, and findings in 9 patients are presented, 
8 with LNC after radiation therapy for Hodgkin's disease, 
and, one with LNC after therapy for non-Hodgkin's 
lymphoma. A summary of the findings in the 8 patients with 
HD and LNC after therapy is given in the Table, and the 
remaining patient is reported in more detail. 
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table 
Summary of patient dala (Hodgkm s disease) 
Case 
No 
' 
2 
3 
4 
5 
6 
7 
8 
5сд 
F 
F 
F 
F 
M 
F 
M 
F 
Initial diagnosis 
Year 
1956 
1964 
1967 
1968 
1970 
1973 
1974 
1980 
Age 
41 
19 
23 
29 
20 
21 
32 
30 
Locali­
zation 
Mediastinum. 
supraclav 
* 
Mediastinum, 
cervical 
Mediastinum. 
supraclav , 
cervical 
Mediastinum, 
supraclav , 
cervical 
Mediastinum. 
supraclav 
abd 
Mediastinum, 
cervical 
Mediastinum, 
abd 
His· 
tol 
* 
* 
N S 
N S 
N S 
M C 
N S 
N S 
Stage 
11 
* 
I I 
II 
11 
I I I 
II 
I I I E 
Initial therapy 
RT 
+ 
+ 
+ 
40 Gy, 
mantle 
Tield 
40 Gy. 
mantle 
Held 
40 Gy 
mantle 
Held 
35 Gy, 
para-
lumb 
+ 
49 5 Gy, 
mcdia-
40 Gy, 
para-
lumb 
ChT 
-
" 
+ 
-
+ 
Calcification 
Localualion 
Paratracheal 
Ant media­
stinum 
Ant media­
stinum, 
paratracheal, 
right para-
cavai (abd ) 
Ant media­
stinum 
Ant media 
sdnum 
Ant media­
stinum 
Ant media­
stinum 
Ant media­
stinum 
Time 
to app­
earance 
(yrs)· 
3 
(15) 
(9) 
(14) 
3 
4 
(8) 
(5) 
2 
Clinical course 
Fol­
low 
up 
(yrs) 
28 
20 
17 
16 
14 
I I 
10 
4 
Recur­
rence 
-
-
1974 abd 
1981 abd 
1984 abd 
1971 axilla 
abd 
1979 cervie 
mediast 
1980 axilla 
1981 submaiui 
-
1984 sternum 
Present 
state 
N E D 
N E D 
Alive 
with 
active 
disease 
N E D 
N E D 
N E D 
1 
N E D 
Still 
under 
treat­
ment 
* = data not available N S = nodular sclerosing M С = mixed ccllulanty ( > = earlier post-treatment radiography not available 
RT = radiation therapy ChT = chemotherapy N E D = no evidence of disease 
CASE REPORT 
A 37-year-old male was referred in March 1982 with a lymph 
node mass in the left inguinal region, associated with 
marked edema of the leg and the scrotum. Abdominal CT 
showed the lesion to be continuous with a left-sided psoas 
mass (Fig. 1a). A biopsy yielded the diagnosis of NHL 
(immunoblastic type). Treatment consisted of combination 
chemotherapy, irradiation (32 Gy) and again chemotherapy. 
The lesion diminished in size but did not disappear 
completely. 
In August 1983, the disease reappeared in the left 
inguinal and right cervical nodes. Soft tissue 
calcifications in the left para-iliac lymph node region 
were then noted at CT (Fig. lb) and at radiography of the 
pelvis. Despite combined treatment modalities, the patient 
died in December 1983 with widespread disease, confirmed 
at autopsy. 
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DISCUSSION 
The first description of spontaneous lymph node 
calcification in HD dates back to 1956, a case record of 
the Massachusetts General Hospital (5) presenting a 
patient with HD in calcified pelvic lymph nodes. In the 
discussion of this case an allusion is made to 2 cases of 
LNC occurring after radiation therapy. Those cases are 
probably part of the series of 9 patients described by 
Wyman & Weber in 1969 (28). This latter report describes 
the occurrence of LNC in HD after radiation therapy in 
more detail. The publication of Reboul 6 Delorme in 1956 
(21) on 4 cases with -what they assumed to be-
'mediastinal pleural calcifications' after irradiation for 
HD is probably the first on this subject. 
Incidence and occurrence. Twenty-two reports on LNC after 
radiation therapy for HD, comprising altogether 61 
patients were assembled from the literature (3,4,6,7,9-17, 
19-26,28) However, this phenomenon should not be so 
infrequent, as various authors found an incidence of LNC 
after irradiation in up to 6.5 per cent and 8 per cent of 
their patients (3,22). The age of the patients at the 
onset of disease varied from 11 to 68 years, with a mean 
age of 30 years (males 32 years, females 28 years). The 
interval between treatment and registration of 
calcification varied from 5 months to 19 years (mean 
interval 5 years). Sex distribution in a group of 47 
patients showed a 5:3 ratio with female preponderance. Of 
18 cases with the current histologic subclassification for 
HD specified, 10 were in patients with the nodular 
sclerosing type. This is compatible with the predominance 
of this type in an average population of patients with HD. 
The data on the 8 patients in the present table all fit 
well into this incidence profile. It should be noted that 
a closely spaced follow-up was not available in all cases. 
In the cases with an adequate radiologic follow-up (cases 
1,4,5,8) the mean time before appearance was 3 years. 
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The occurrence of LNC in NHL seems to be more uncommon, as 
only 4 cases could be traced in the literature (2,6). 
Calcification was noted between 4 and 7 months after 
treatment. In the case described in this report 
calcification was noted on a CT scan 17 months after the 
initial treatment. A radiograph of the involved area 
revealed subtle punctate and streaky calcium deposits. In 
4 cases of LNC after chemotherapy mentioned in the 
literature, calcification was noted between 4 months and 5 
years after treatment (1,2,6). Finally, as far as is 
known, only 3 cases of LNC in untreated HD have been 
described (5,8,27). In all cases, histologic confirmation 
of nodal involvement was available. 
Radiogra£hic_a£pearanee. Post-therapy lymph node 
calcification occurs only in abnormal nodes. It usually 
starts as fine, punctate calcific densities, gradually 
assuming a coarse, nodular or confluent appearance (3,6,9, 
10,28) (Fig. 2). With time, the area of calcification may 
shrink, leading to a denser and more nodular structure. 
The area of calcification gradually increases in size 
(Fig. 3a-d) without concomitant lymph node enlargement. In 
about 20 per cent of cases a more or less continuous 
peripheral, rim-like calcification appears, the so-called 
egg-shell type (6,10,13,28). The radiographic appearance 
is similar in HD and in NHL, after irradiation and 
chemotherapy, and in spontaneous or post-therapy 
calcification. In fact, the radiographic image is non-
specific and can be seen in a variety of other diseases 
such as tuberculosis, sarcoidosis, histoplasmosis, 
silicosis, and other disorders as well (14, 25, 28). In 
all the present cases with LNC in the mediastinum or the 
pulmonary hilar region, there was also paramediastinal 
fibrosis due to mantle-field irradiation (Fig. 2b, 3a). 
Calcified lymph nodes mostly appear in the upper 
mediastinum, although in many patients other involved 
lymph node regions have been treated in the same way. 
However, LNC outside the thorax does occur (6,19,20) 
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Fig. Is Case 9, non-Hodgkin's lymphoma, a) CT scan shows increased 
volume of iliopsoas coqpartment, thickening of gluteal 
muscles and subcutaneous edema on the left side, b) CT scan 
after treatment. Decrease of tumor volume. Soft tissue 
calcification in left parailiac region. 
(F ig . 3 e ) . The cases of spontaneous LNC repor ted in t he 
l i t e r a t u r e showed a predominant punc ta te c a l c i f i c a t i o n . 
C l i n i c a l _ s i g n i f ^ c a £ œ . P o s t - i r r a d i a t i o n lymph node 
c a l c i f i c a t i o n i s sa id to occur mainly in young females 
with massive m e d i a s t i n a l lymph node involvement and with 
p re fe rence for the nodular s c l e r o s i n g form of HD ( 1 0 , 1 4 ) . 
However, in t he review of the l i t e r a t u r e , and inc luding 
t h e p re sen t o b s e r v a t i o n s , both s exes , a l l ages , s t ages and 
h i s t o l o g i c types of HD have been descr ibed in conjunct ion 
with LNC. 
The occurrence of c a l c i f i c a t i o n i s u sua l l y a s s o c i a t e d with 
a good prognos is with regard t o s u r v i v a l . Relapse of t he 
d i s e a s e in t h e s e p a t i e n t s does occur , but only r a r e l y in 
the a rea of c a l c i f i c a t i o n ( 1 0 , 1 4 , 2 2 , 2 8 ) . The 8 p a t i e n t s 
with LNC a f t e r i r r a d i a t i o n in t he p r e s e n t r epo r t have 
survived for 4 t o 28 yea r s a f t e r the i n i t i a l d i agnos i s and 
t r e a t m e n t . Four p a t i e n t s suffered from a r e l a p s e , but 
could be t r e a t e d s u c c e s s f u l l y . In the n in th c a s e , a 
p a t i e n t with non-Hodgkin's lymphoma, the course of t he 
- I l l -
Fig. 2: Case 4, Hodgkin's disease, a, с) At i n i t i a l presentation a 
large anterior mediastinal lymph node mass i s present, b, d) 
Thirteen years after radiation therapy coarse nodular 
calcifications in the left anterior mediastinum. Also 
moderate paramediastinal fibrosis. 
d i s e a s e was more d r a m a t i c . Despi te combined t r e a t m e n t 
m o d a l i t i e s , r e c u r r e n c e and p r o g r e s s i o n of t h e d i s e a s e led 
t o death 21 months a f t e r the i n i t i a l d i a g n o s i s . 
C a l c i f i c a t i o n in lymph nodes a f t e r t h e r a p y probably occurs 
in a r e a s with hemorrhage and n e c r o s i s , where f i b r o u s 
hea l ing subsequent ly fol lows ( ' d y s t r o p h i c c a l c i f i c a t i o n ' ) 
( 1 , 1 9 ) . Though t h e r e appears t o e x i s t an increased chance 
of c a l c i f i c a t i o n a f t e r higher doses of r a d i a t i o n , LNC i s 
a l s o noted a f t e r r e l a t i v e l y low doses ( 3 , 6 , 1 6 , 2 2 , 2 8 ) . 
Some a u t h o r s hold t h a t c a l c i f i c a t i o n r e f l e c t s h e a l i n g and 
can t h e r e f o r e be regarded as a more or l e s s s u c c e s s f u l 
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host reaction to the tumor (3,11). This concept should 
tally well with the occurrence of long-term survival in 
many of these patients. Foci of necrosis can at times be 
observed histologically in untreated Hodgkin tissue (18), 
although calcification in these areas is apparently very 
rare. This fact might nevertheless explain the potential 
for spontaneous calcification in punctate form, as 
reported in the literature. 
Fig. 3: 
Case 3. Hodgkin's disease, a) chest film, 16 years after diagnosis 
and treatment. Marked (para) mediastinal fibrosis. b,c) lateral view 
(detail) shows this anterior mediastinal calcification in 1976 (b) 
and 1983 (c). Slight increase in volane of calcification is apparent 
(arrow) d) CT scan shows retrosternal calcifications e) CT scan of 
abdomen shows calcification in paracaval nodes (arrows). 
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β.1 THE ABDOMEN 
8.1.1 The lymph nodes 
Literature data correlating radiologic and histologic 
findings in infradiaphragmatic lymph nodes in patients 
with Hodgkin disease (HD) and/or patients with non-Hodgkin 
lymphoma (NHL) invariably show a lower diagnostic accuracy 
of CT in comparison with lymphography.This difference is 
due to the lower sensitivity of CT. This is the direct 
result of the fact that lymphography visualizes both 
lymph-node size and structure, whereas CT judges 
lymph-node size only. Architectural changes in normal 
sized nodes escape detection with CT. 
In the present study the comparative diagnostic 
performance of CT and lymphography have been evaluated in 
patients with HD (chapter 2) and in patients with NHL 
(chapter 4). The final conclusions of both studies 
concurred. 
Lymphography was abnormal in 17% of patients with HD 
having a normal CT scan, and in 17% of the patients with 
NHL having a normal CT scan. This discrepancy occurred 
mainly when CT was performed first. Conversely, when 
lymphography appeared to be normal, CT only occasionally 
detected abnormalities in infradiaphragmatic nodes, even 
though CT is able to visualize more lymph-node regions. 
The following conclusions with regard to staging can be 
drawn: 
* Lymphography remains the single, most accurate 
radiologic examination of abdominal nodes. When 
lymphography is either normal or abnormal, additional 
CT only rarely influences the final staging data. 
* The advantages of CT in comparison with lymphography 
are that CT is easier and faster to perform, is less 
invasive than lymphography and imposes less discomfort 
on the patient. Repeat studies with good reproducibi­
lity are possible during surveillance of the patient. 
Follow-up studies with lymphography are also easy to 
perform with visualization of minimal changes in size 
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and structure, but only in a period of about 1 year 
after the initial examination. For further follow-up, 
repeat injections of contrast are then required. 
For these practical purposes, CT is usually preferred 
as the first examination in the staging of patients 
with malignant lymphoma, despite its lower diagnostic 
yield. In this set-up, lymphography only adds 
information in a minority of patients, i.e. when CT is 
normal or equivocal. If an abnormal lymphogram would 
not influence subsequent management after a normal 
CT scan, it can be omitted. 
* CT gives a more complete survey of the infradiaphrag-
matic lymph-node state than bipedal lymphography. 
However, it cannot compensate for the shortcomings of 
lymphography that became evident by carrying out 
staging laparotomy. In fact, the lower sensitivity of 
CT in comparison with lymphography indicates that 
staging laparotomy will continue to play a part when 
exact information on disease extent is mandatory. 
8.1.2 The spleen 
Non-invasive examinations of the spleen are historically 
unreliable in evaluating the presence or absence of 
lymphoma. As argued, in chapters 3 and 5, it appeared from 
literature data, that a more exact determination of spleen 
size with CT might increase the diagnostic accuracy. 
The "splenic index" (= width χ length χ thickness) appeared 
to be useful for better definition of*spleen size, and for 
discrimination of uninvolved from involved spleens. 
In a series of 35 patients with HD undergoing laparotomy 
with splenectomy, a diagnostic accuracy of 91% was ob­
tained with a specificity of 94% and a sensitivity of 89%. 
With patients having NHL, splenic index calculation and 
histologic verification were only possible in a heavily 
selected group of patients, and the diagnostic accuracy 
amounted to 100%. The (extrapolated) accuracy, specificity 
and sensitivity in a group of 20 patients without spleen 
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histology available, amounted to 90%, 100% and 82% 
respectively. These biased results indicate that splenic 
index calculation can be of value. It is questionable 
whether the hypothesis can be substantiated further, 
because of the lack of laparotomy data. 
8.2 THE CHEST 
The role of radiologic examinations of the chest in 
staging patients with malignant lymphoma is discussed in 
chapter 6. 
Chest radiography was supplemented by tomography of the 
mediastinum in 52 patients with malignant lymphoma. No 
additional information was obtained in patients with a 
clearly normal or abnormal chest radiograph. Only in the 
event of an equivocal chest radiograph a tomogram was 
helpful. 
CT on the contrary, revealed abnormalities in 7% of 
patients with a normal chest radiograph. CT detected 
minimal to moderately enlarged mediastinal or parasternal 
lymph nodes that were not visible with chest radiography. 
In 23% of the patients with an abnormal chest radiograph, 
additional lesions were found with CT, mostly in the form 
of pulmonary nodules. On the whole, CT changed the clini-
cal stage of disease in only 3% of patients in whom it was 
performed, and this only occurred in patients with HD. 
It is advised to perform CT not routinely in patients with 
malignant lymphoma, but to reserve it for those cases in 
which treatment strategy will be modified due to the 
additional positive findings. 
8.3 UNCOMMON MANIFESTATIONS 
The radiologic observation of calcification in lymph nodes 
afflicted with HD is an uncommon occurrence (chapter 7). 
This phenomenon is associated with a good prognosis. The 
incidence of lymph node calcification in NHL is too rare 
to draw conclusions with regard to clinical significance. 
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8.4 INLEIDING 
"Maligne lymfomen" is de verzamelnaam voor kwaadaardige 
aandoeningen die uitgaan van het lymfatische systeem. Er 
worden 2 hoofdgroepen onderscheiden: de ziekte van Hodgkin 
(afgekort: MH) en de zogenaamde non-Hodgkin lymfomen 
(afgekort: NHL). Deze ziekten tasten meestal de lymfklie-
ren aan, maar kunnen ook voorkomen in alle andere organen 
(milt, lever, beenmerg, maagdarmstelsel, longen etc). 
De maligne lymfomen waren in 1983 verantwoordelijk voor 
2.7% van de totale kankersterfte in Nederland (863 perso-
nen) . Daar staat tegenover dat veel patiënten -vooral met 
MH- door de moderne behandelingsmogelijkheden worden 
genezen, of langdurig in een goede toestand kunnen worden 
gehouden bij niet volledige genezing. 
De vorm van behandeling hangt mede af van de uitgebreid-
heid (stadium) van de ziekte. Röntgenonderzoek zoals lym-
fografie, computertomografie (CT) van borst- en buikholte, 
longfoto's en gewone planigrafie kan tal van lymfklier-
stations en organen zichtbaar maken, en vormt een belang-
rijk onderdeel van het zogenaamde stadiëringsonderzoek. 
In dit proefschrift wordt nagegaan wat de mogelijkheden en 
beperkingen zijn van verschillende radiologische onder-
zoektechnieken. Getracht wordt de vraag te beantwoorden in 
hoeverre diverse onderzoeken elkaar aanvullen dan wel 
overlappen, hoe betrouwbaar zij zijn in het aantonen van 
de ziekte-uitbreiding, en op welke manier zij ingepast 
kunnen worden in het stadiëringsonderzoek. 
MH en NHL worden apart besproken -niet alleen vanwege de 
histopathologische verschillen- maar ook vanwege verschil-
len in klinische presentatie, gedrag en prognose. 
In hoofdstuk 2 en 4 wordt CT van de buik met lymfografie 
vergeleken. Waar mogelijk, wordt tevens gecorreleerd met 
histologische bevindingen bij laparotomie. In hoofdstuk 3 
en 5 wordt de waarde van CT met betrekking tot het onder-
zoek van de milt geëvalueerd. In hoofdstuk 6 wordt het 
onderzoek van de thorax besproken. Hoofdstuk 7 staat los 
van het stadiëringsonderzoek, en demonstreert enkele onge-
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wone radiologische verschijningsvormen. 
8.5 DE BUIK 
6.5.1 De lymfklieren (hfdst. 2 en 4 ) 
Literatuur gegevens met betrekking tot het radiologisch en 
histologisch onderzoek van de lymfklieren onder het dia-
fragma bij patiënten met MH of met een NHL wijzen op een 
lagere betrouwbaarheid van CT vergeleken met lymfografie, 
als gevolg van een lagere sensitiviteit. Dit is het gevolg 
van het feit dat met CT alleen de grootte van de lymfklie-
ren wordt beoordeeld, terwijl lymfografie behalve de 
grootte ook de inwendige structuur zichtbaar maakt. De 
conclusies uit eigen onderzoek komen overeen met de 
literatuur en stemmen overeen bij patiënten met MH en 
NHL. Lymfografie liet afwijkingen zien in de lymfklieren 
bij 17% van de patiënten met MH, en bij 17% van de patiën-
ten met NHL, bij wie de CT-scan normaal was. De discrepan-
ties traden voornamelijk op wanneer CT vóór de lymfografie 
was verricht. Met CT werden zelden afwijkingen aangetoond 
wanneer de lymfografie normaal was. 
De volgende conclusies worden getrokken met betrekking tot 
het stadiëringsonderzoek: 
* lymfografie is het meest nauwkeurige onderzoek van de 
abdominale lymfklieren. Na een normaal of abnormaal 
lymfogram levert een CT scan zelden, voor de stadiëring 
relevante, extra gegevens op. 
* CT is gemakkelijker en sneller uit te voeren dan lymfo-
grafie, en is minder belastend voor de patiënt. Herha-
lingsonderzoeken, met goede reproduceerbaarheid zijn 
eveneens gemakkelijk uitvoerbaar. 
Lymfografie is een enigzins invasief onderzoek, en duurt 
in vergelijking met CT betrekkelijk lang. Controle-
onderzoeken zijn daarentegen sneller en gemakkelijker 
uitvoerbaar, en maken minimale veranderingen in de klie-
ren reeds zichtbaar. Gemiddeld is na ± 1 jaar het 
contrastmiddel zover verdwenen dat controle niet meer 
mogelijk is, en zou opnieuw contrastmiddel moeten worden 
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ingebracht. 
Om praktische redenen wordt CT meestal als eerste onder-
zoek verkozen, ondanks de iets lagere betrouwbaarheid. 
Een lymfografie is alleen dan zinvol wanneer de CT géén, 
of onduidelijke afwijkingen laat zien. Als een afwijkend 
lymfogram na een normale CT scan het beleid evenwel niet 
beïnvloedt, kan het achterwege worden gelaten. 
* CT geeft een vollediger beeld van de lymfklieren onder 
het diafragma dan lymfografie. Echter, de tekortkomingen 
van lymfografie die bij stadiëringslaparotomie aan de 
dag traden worden met CT niet opgevangen. Stadiërings-
laparotomie zal in voorkomende gevallen niet vermeden 
kunnen worden. 
8.5.2 De milt (hfdst. 3 en 5) 
Het niet-invasieve onderzoek van de milt (palpatie, rönt-
genfoto, nucleaire scan) is in het verleden niet erg 
betrouwbaar gebleken met betrekking tot het aantonen of 
uitsluiten van lymfoom localisaties. Uit literatuurgege-
vens kregen wij de indruk dat door een meer exacte bepa-
ling van de miltgrootte met CT de betrouwbaarheid verhoogd 
zou kunnen worden. Hiertoe werd aan de hand van de 
CT-scans de zogenaamde miltindex berekend (= lengte χ 
breedte χ dikte). Een waarde van 480 werd gehanteerd als 
grens tussen normale en vergrote milten, resp. 
histologische normale en aangetaste milten. 
Bij 35 patiënten met MH bij wie de milt verwijderd werd, 
bleek het mogelijk op deze manier een diagnostische nauw-
keurigheid van 91% te behalen (6% fout-positieve en 11% 
fout-negatieve diagnoses). 
Bij 33 patiënten met NHL was de milt beschikbaar voor his-
tologisch onderzoek, en de diagnostische betrouwbaarheid 
van de miltindex berekening bedroeg 100%. Bij 20 andere 
patiënten met NHL werd de milt "indirect" geëvalueerd, 
waarbij een betrouwbaarheid van 90% werd verkregen met 0% 
fout-positieve en 18% fout-negatieve diagnoses. 
Echter, deze beide NHL-groepen bestonden uit zeer geselec-
teerde patiënten, zodat de resultaten geen absolute waarde 
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hebben, maar gezien moeten worden als aansporing tot verder 
onderzoek. Dit zal echter waarschijnlijk niet mogelijk zijn 
omdat stadiëringslaparotomieën, die het materiaal moeten 
leveren, nog slechts sporadisch worden verricht bij patiën-
ten met NHL. 
Het "addendum" na hoofdstuk 3 plaatst enkele kanttekeningen 
bij onze waarnemingen. 
8.6 DE THORAX (hfdst. 6) 
Bij 52 patiënten werd behalve een thoraxfoto in achtervoor-
waartse en zijdelingse richting ook een planigrafie (= to-
mografie) van het mediastinum verricht. In geen van de ge-
vallen waarin de thoraxfoto duidelijk normaal of abnormaal 
was, werd de conclusie gewijzigd. Alleen wanneer de thorax-
foto twijfelachtige bevindingen liet zien, droeg de plani-
grafie bij aan de vorming van een zekere uitspraak. 
Bij 76 patiënten werd een CT-scan van de thorax verricht. 
Bij 7% van de patiënten met een normale thoraxfoto werden 
toch afwijkingen gevonden, in de vorm van licht tot matige 
vergrote klieren. Bij 23% van de patiënten met een afwij-
kende thoraxfoto werden met CT extra afwijkingen gevonden. 
Evenwel, over de gehele groep gezien, veranderde de CT het 
klinisch stadium in slechts 3% van de patiënten, en dan nog 
uitsluitend bij patiënten met MH. Het routinematig verrich-
ten van CT van de thorax bij iedere patiënt die gestadieerd 
wordt vanwege maligne lymfoom lijkt derhalve niet zinvol. 
Alleen in die gevallen waarin de extra bevindingen het be-
leid beïnvloeden, is CT aangewezen. 
8.7 ONGEWONE BEELDEN (hfdst. 7) 
Verkalkingen in lymfklieren bij MH worden zelden radiolo-
igisch aangetoond, en dan vrijwel uitsluitend na bestraling. 
'Bit fenomeen gaat gepaard met een goede prognose. Dit 
blijkt uit de literatuur, en uit een groep eigen patiënten. 
Verkalkingen in klieren na behandeling wegens NHL zijn zeer 
zeldzaam, en de klinisch betekenis ervan is niet duidelijk. 
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WOORDEN VAN DANK 
Velen hebben bijgedragen aan de totstandkoming van dit 
proefschrift. Aan de praktis-che uitvoering van de honder-
den röntgenonderzoeken hebben tientallen radiodiagnostisch 
laboranten (m/v) meegewerkt, terwijl vele assistenten zich 
met meer of minder enthousiasme over de uitvoering van de 
lymfografieën hebben gebogen. 
Belangrijke patiëntengegevens werden verkregen dank zij de 
medewerking van de afdelingen Hematologie (hoofd: Prof.Dr. 
C. Haanen), Radiotherapie (hoofd: Prof.Dr. W.A.J. van 
Daal), en Medische Oncologie (hoofd: Prof.Dr. D.J.Th. 
Wagener). 
Niet minder waardevolle gegevens werden mij verschaft door 
medewerkers van de afdeling Pathologische Anatomie (hoofd: 
Prof.Dr. G. Vooys) en Algemene Chirurgie (hoofd: Prof.Dr. 
H.H.M, de Boer). 
Voor de foto's in de oorspronkelijke artikelen, en in dit 
proefschrift dank ik de heren W. Witte en Th. Janssen. 
De heer K. Jannink was mij behulpzaam bij het terugzoeken 
van de foto's en bijbehorende gegevens. 
Het vele typewerk voor de oorspronkelijke artikelen werd 
verzorgd door Sjana Serhalawan en Bernadette Schols-
Müller. 
Het proefschrift zelf werd met veel geduld, toewijding en 
vaardigheid door Sjana Serhalawan verzorgd. 
Tenslotte dank ik mijn collega-stafleden voor de gelegen-
heid die mij is geboden dit proefschrift af te ronden. 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd geboren op 22 maart 
1947 te Leiden. Aan het St. Bonaventura Lyceum aldaar werd 
in 1965 het einddiploma gymnasium-ß behaald. Hij studeerde 
geneeskunde aan de Rijksuniversiteit te Leiden, en 
behaalde in november 1972 het artsexamen. 
De militaire dienstplicht werd tot maart 1974 vervuld op 
de afdeling Radiologie van het Militair Hospitaal 
'Dr. A. Matthijsen' te Utrecht, onder leiding van de 
radiologen A. v.d. Beek en J.M.H. Blom. 
Op 1 april 1974 begon hij zijn opleiding radiodiagnostiek 
in het St. Radboudziekenhuis te Nijmegen (Hoofd: Prof.Dr. 
Wm. Penn). 
Na zijn inschrijving in het specialistenregister per 
1 april 1978, is hij als staflid verbonden aan het 
Instituut voor Radiodiagnostiek van het St. Radboud-
ziekenhuis (hoofd tot 1982: Prof.Dr. Wm. Penn; thans 
Prof.Dr. J.H.J. Ruijs). Tot zijn deel-vakgebied behoren 
alle (diagnostische, interventionele en oncologische) 
aspecten van de abdominale radiologie. 
STELLINGEN 
1. Het verschil in diagnostische nauwkeurigheid tussen CT 
en lymfografie bij patiënten met maligne lymfoom berust 
voornamelijk op een verschil in sensitiviteit ten 
nadele van CT. 
2. CT is geen alternatief voor stadiëringslaparotomie. 
3. De informatie verkregen met behulp van CT en lymfo-
grafie is voor 85% overlappend en voor 15% aanvullend. 
Tegenstrijdige informatie kan meestal afdoende ver-
klaard worden. 
4. Het routinematig verrichten van een CT van de thorax 
als onderdeel van het stadiëringsonderzoek bij patiën-
ten met de ziekte van Hodgkin of non-Hodgkin lymfoom is 
niet zinvol. 
5. De in-vivo bepaling van de miltgrootte met behulp van 
de CT-miltindexberekening kan aanwijzingen geven over 
eventuele lymfoomlocalisatie in de milt bij .patiënten 
met de ziekte van Hodgkin of non-Hodgkin lymfoom. 
6. Het optreden van lymfklierverkalkingen bij de ziekte 
van Hodgkin is een prognostisch gunstig teken. 
7. Het verrichten van een lymfografie na een abdominale 
CT-scan levert alleen additionele informatie op wanneer 
de CT géén of twijfelachtige afwijkingen laat zien. 
8. Magnetic Resonance Imaging (MRI) is een gevoelige 
methode voor het opsporen van afwijkingen in het been-
merg bij patiënten met leukemie, maligne lymfoom of 
metastasen. 
(DO Olson et al., Invest. Radiol. 1986; 21: 540-546). 
9. Wanneer bij patiënten met een niet-seminomateuze 
testistumor wordt gekozen voor een zogenaamd "wait and 
see" beleid, dan dient bij screening op retroperitone-
ale lymfkliermetastasen zowel een abdominale CT-scan 
als een lymfografie te worden verricht. 
10. Bij de bepaling van de resectabiliteit van een 
pancreastumor kan een percutané transhepatische porto-
grafie (РТР) bij een groot deel van de patiënten worden 
vermeden door het uitvoeren van een intra-arteriële 
digitale subtractie angiografie (i.a. DSA) van de 
a. mesenterica superior en de truncus coeliacus. 
11. Bij vergelijking van de mortaliteit van palliatieve be-
handeling voor maligne galgangobstructie door percuta-
né, endoscopische of chirurgische drainage, dient met 
name gelet te worden op het aanwezig zijn van een ver-
laagd serum-albuminegehalte en een verhoogd bloed-
ureumgehalte als prognostisch ongunstige variabelen. 
(D Bonnel et al.. Radiology 1984; 152: 347-351.) 
12. Bij patiënten met manifestaties van het solitair rectum 
ulcus syndroom is een defecografie geïndiceerd om een 
functionele defecatiestoornis op te sporen. 
(JHC Kuijpers et al., wordt gepubliceerd in Ned. Tijdschr. Ge-
neeskd.) 
13. Echografisch zichtbare, zwevende stenen in de (niet-
geopacificeerde) galblaas bevatten zeer waarschijnlijk 
gas (Mercedes Benz fenomeen). 
(SP Strijk et al., Gastrointest. Radiol. 1981; 6: 261-263.) 
14. De radiodiagnost kan bijdragen aan vermindering van het 
aantal diagnostische verrichtingen door de aanvraag net 
zo kritisch te beoordelen als de foto's. 
Nijmegen, 16 januari 1987 S.P. Strijk 


